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ABSTRACT 
THE IDENTIFICATION AND CHARACTERIZATION OF A GROUP OF ER TPR-
CONTAINING ADAPTER PROTEINS  
September 2014 
JOHAN C. SUNRYD, B.S., MICHIGAN STATE UNIVRSITY 
Ph.D., UNIVERSITY OF MASSACHUSETTS AMHERST 
Directed by: Professor Daniel Hebert 
 
The endoplasmic reticulum (ER) is an organelle responsible for a variety of functions in 
all eukaryotic cells. Some of these functions are localized to specific regions in the ER, such as 
the ribosome-studded rough ER sheets or the ribosome-free smooth ER sheets. The smooth ER 
sheets have the ability to form ER tubules, which extend throughout the cell and make contact 
with other organelles. In order to accommodate these localized functional regions, a certain 
degree of heterogeneity and compartmentalization into sub-domains exists within the ER. Since 
the ER membrane and lumen are contiguous, the compartmentalization of the ER into sub-
domain cannot exclusively be created by membrane barriers. Adapter proteins nucleate the 
formation of protein complexes to create sub-domains in the ER. Tetratricopeptide repeats (TPR) 
containing proteins are known to organize protein complexes involved in a wide range of cellular 
processes. While the human genome is predicted to encode ~ 180 TPR proteins, only two have 
previously been shown to localize to the ER. We hypothesized that there are additional TPR-
containing adapter proteins that contribute to the organization or compartmentalization of ER 
processes. To this end, we screened an in silico library of putative TPR containing proteins from 
the Regan laboratory (Yale University) to identify proteins that potentially possess an N-terminal 
ER targeting signal sequence. This screen, combined with additional in silico approaches, 
identified nine putative ER proteins that contained between three to ten TPR motifs. While some 
of the identified proteins are soluble ER proteins (i.e. TTC13 and TTC17), others were found to 
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reside in the ER membrane with their TPR domains facing the ER lumen (TMTC1-4). TMTC1 
and TMTC2 were found to interact with the ER calcium pump SERCA2B, and TMTC2 with 
calnexin. Additionally, live cell calcium measurements showed a role for TMTC1 and TMTC2 in 
calcium homeostasis. Overall, this strategy was successful in identifying novel ER proteins with 
TPR motifs, and this approach can be applied to identify proteins with specific motifs in the ER 
or other organelles. 
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CHAPTER 1 
 
THE COMPARTMENTALIZATION AND ORGANIZATION OF THE ENDOPLASMIC 
RETICULUM 
 
Introduction 
The endoplasmic reticulum (ER) is the gateway to the secretory pathway, and 
approximately one third of the human genome encodes proteins targeted to the ER. A number of 
cellular functions such as secretory protein folding, degradation of terminally misfolded secretory 
proteins, trafficking of secretory proteins, calcium homeostasis, lipid synthesis and xenobiotic 
metabolism are all dependent upon the ER and ER-resident proteins (Figure 1.1A) (Leitman et 
al., 2013; Lynes and Simmen, 2011). Early electron microscopy studies highlight morphological 
differences between regions of the ER categorizing these regions as rough and smooth ER sheets. 
The rough ER sheets are studded with ribosomes while the smooth ER sheets lack ribosomes 
(Figure 1.1B) (Palade and Siekevitz, 1956). These ER sheets are connected by helicoidal turns, 
and the low curvature of these turns allows docking of ribosomes (Terasaki et al., 2013). The 
smooth ER contains proteins that enhance membrane curvature that form tubules; which have the 
ability to fuse and separate (Voeltz et al., 2006). Additionally, the ER is highly dynamic and 
capable of changing its morphology from sheets to tubules, and vise versa, as the need arises 
(Friedman and Voeltz, 2011). The ER sheets and tubules extend throughout the cell. 
The dispersal of the ER allows for discrete contact points to form between the ER and 
other organelles such as the mitochondria, plasma membrane, pre-peroxisomal compartments and 
the cytoskeleton. The ER membrane is also contiguous with the nuclear envelope. Interactions 
between the ER and other organelles and the cytoskeleton influence its shape, size and movement 
in the cell (Voeltz et al., 2006). In eukaryotes, the movement of the ER is guided along 
microtubules by motor proteins (Nikonov et al., 2007), and although the actin cytoskeleton is 
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important for yeast and plant ER, it is not for mammalian ER (Liebe and Menzel, 1995; Prinz et 
al., 2000). Collectively, these data demonstrate a high level of organization within the ER and 
that the shape and movement of the ER are highly dynamic. 
Although the luminal space of the ER exists as an unbroken unit without interruptions, it 
nevertheless appears to possess some heterogeneity in protein composition among the different 
regions. The clearest example of this is in the rough ER, which is enriched with translating 
ribosomes. More recent work has demonstrated an enrichment of certain factors at contact sites 
between the ER and various organelles (Lynes and Simmen, 2011). Further experimental support 
for the compartmentalization of the ER was shown by accumulation of both soluble and 
membrane proteins required for disposal of misfolded secretory proteins in a specific region of 
the ER (Lederkremer, 2009). Proteomic studies further support the heterogeneity of the ER as 
most ER proteins have a preferential localization in rough versus smooth ER (Gilchrist et al., 
2006). On the whole, a growing body of work suggests that the diverse functions of the ER are 
localized to specific sub-domains within this continuous lumen. 
Rough ER sheets 
The ribosome studded rough ER sheets, which are essential for co-translational insertion 
of secretory proteins into the ER, were the first example of ER sub-domains (Figure 1.2) (Schnell 
and Hebert, 2003). At the rough ER, proteins with a N-terminal signal sequence are inserted co-
translationally as the ribosome docks onto the SEC61 translocation complex located in the ER 
membrane. This large multi-protein complex facilitates the insertion of the nascent protein and 
releases transmembrane domains into the ER membrane as they are synthesized. Alternatively, a 
secretory protein can be targeted post-translationally to the ER by means of an internal 
transmembrane domain (Johnson et al., 2013). Once the nascent protein reaches the ER lumen, a 
plethora of covalent modifiers, chaperones and foldases aid to enhance the folding efficiency of 
the client protein (Tamura et al., 2010).  
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Secretory proteins commonly acquire disulfides, which are formed in the oxidizing 
environment of the ER with the aid of ER localized oxidoreductase or protein disulfide isomerase 
enzymes. Additionally, most secretory proteins obtain covalent asparagine (N) linked glycan 
during their ER residency. Modification of these sugar structures by ER localized enzymes allow 
for recruitment of ER resident lectin chaperones to aid glycoprotein folding (Hebert et al., 2005). 
Protein maturation is further augmented by a number of chaperones that recognize misfolded 
proteins independently of N-linked glycans (Pearse and Hebert, 2010). The collective aim of 
these covalent modifications and chaperones in the ER is to guide the folding of the client 
proteins to a functional state. Once deemed properly folded by the ER quality control machinery, 
a protein can be targeted for trafficking to other parts of the secretory pathway. 
Smooth ER sheets and tubules 
Proteins selected for secretion move from the rough ER to the ER exist sites (ERES), 
which are located in the smooth ER (Figure 1.2). The ERES are characterized by the presence of 
SEC16A and SEC16B, which recruit components of COPII vesicles to the cytoplasmic side of the 
ER membrane to form vesicles (Watson et al., 2006). These vesicles buds off from the ER 
membrane and head to the ER-Golgi intermediate compartment and Golgi for further processing 
and sorting (Bhattacharyya and Glick, 2007). The process of selection for secretion through 
ERES is poorly understood. Some membrane proteins are selected for secretion by diacidic 
motifs in their cytoplasmic C-terminal tails, which recruits components of the COPII vesicles for 
proper secretion (Nishimura and Balch, 1997; Nishimura et al., 1999). Additionally, it is possible 
that changes in local lipid or cholesterol composition of the ER membrane could play a role. ER 
resident membrane proteins have slightly shorter transmembrane domains than other membrane 
resident proteins, which is attributed to the difference in lipid composition of the respective 
membranes. Additionally, fusing a 17 or a 22 amino acids transmembrane domain to ER targeted 
fluorescent proteins resulted in either ER retention or ERES dependent secretion, respectively 
4 
 
(Ronchi et al., 2008). Thus, lipid composition, length of transmembrane domains as well as ER 
resident and cytoplasmic proteins aid in proper trafficking of proteins through the ERES. Thus, 
the ERES are critical in shuttling proteins deemed as properly folded out of the ER toward their 
intended destination. 
As protein folding and maturation is an error-prone process, a fraction of secretory 
proteins inevitably misfold and must be rapidly degraded to prevent toxic build up (Smith et al., 
2011). These misfolded secretory proteins are recognized in the ER, by a process named ER-
associated degradation (ERAD). The ERAD substrate is recognized by ERAD receptors and 
targeted to a retrotranslocation complex in the ER membrane, retrotranslocated, ubiquitinated in 
the cytoplasm, extracted from the ER membrane and ultimately degraded by the 26S proteasome. 
A number of ERAD factors are localized to a sub-domain of the ER called the ER quality control 
compartment (ERQC) (Figure 1.2) (Avezov et al., 2008; Kondratyev et al., 2007). It has been 
proposed that adapter proteins, which nucleate multiprotein complexes required for the disposal 
of aberrant secretory proteins, maintain the ERQC. SEL1L is an ER type I membrane adapter 
protein that interacts with multiple ER luminal and membrane proteins required for ERAD, and 
could aid in the maintenance of the ERQC (Christianson et al., 2008; Mueller et al., 2006). The 
protein complex nucleated by SEL1L is believed to contain, among other factors, an unidentified 
pore that forms a channel through the ER membrane and the E3 ligase, HRD1, that ubiquitinates 
misfolded proteins as they emerge into the cytoplasm (Hosokawa et al., 2008; Mueller et al., 
2008). Once ubiquitinated, the cytoplasmic ATPases associated with diverse cellular activities 
(AAA ATPase) p97, provides the mechanical force to extract misfolded proteins from the ER 
membrane and prepare them for proteasomal degradation in the cytoplasm (Stolz et al., 2011; Ye 
et al., 2001).  
While the SEL1L-HRD1 complex is the best-studied E3 ligase complex in the ER 
membrane, it is important to note that the ER contains approximately 40 E3 ligases, some of 
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which are completely uncharacterized (Claessen et al., 2012; Neutzner et al., 2011). Thus, it is 
possible that there are unknown paralogues of SEL1L that aid in the organization of proteins 
involved ERAD and ERQC. 
Despite the efforts by quality control machinery and the rapid disposal of the failures by 
ERAD, misfolded proteins can nevertheless accumulate in the ER and activate the unfolded 
protein response (UPR) (Figure 1.2) (Hetz, 2012; Yoshida et al., 2001). The UPR is a diverse ER 
rescue mechanism that has three distinct branches in mammals, mediated by ATF6, IRE1α and 
PERK. These proteins initiate various signaling pathways that aim to repress general protein 
translation, increase translation of chaperones, enhance degradation of misfolded proteins, 
activate autophagy and expand the size of the ER (Hetz, 2012; Ng et al., 2000). While all three 
branches of the UPR are activated by severe ER stress, differences in responses to the three 
branches to some forms of ER stress have been observed (DuRose et al., 2006). Although 
originally considered to be activated solely by the accumulation of unfolded proteins, the UPR 
has also been implicated in glucose metabolism, innate immunity and cell differentiation 
(Hotamisligil, 2010; Iwakoshi et al., 2003; Martinon and Glimcher, 2011). Notably in B-cells, the 
UPR is activated prior to immunoglobulin synthesis, indicating that UPR can be activated before 
ER stress occurs (Cenci and Sitia, 2007; Hu et al., 2009). Thus, the overarching goal of the UPR 
is to overcome ER stress and restore ER homeostasis. If homeostasis cannot be re-established and 
the stress signal is prolonged, the UPR signal will eventually become proapoptotic and the cell 
will be cleared by apoptosis (Tabas and Ron, 2011). Taken together, the UPR is a broad umbrella 
signal transduction pathway that uses a multi tool approach to maintain ER homeostasis and to 
ensure ER fitness.  
The ER interfaces with multiple organelles 
While the ER consists of an uninterrupted membrane and lumen, the ER appears to 
possess a higher level of compartmentalization, which becomes evident when looking at the 
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discrete contact points between the ER and other organelles (Figure 1.1C) (Leitman et al., 2013). 
These contact points can be considered sub-domains of the ER, enriched in factors that are 
needed for specific functions. Perhaps the clearest ER-organelle interface sub-domain is the 
nuclear envelope, which is a continuation of the ER membrane that wraps around the nucleus. 
Unique to the nuclear envelope are the nesprin family of proteins, which provide a link between 
the lamina and the cytoskeleton by bridging the inner and outer membrane of the nuclear 
envelope, thus influencing shape and positioning of the nucleus in the cell (Mellad et al., 2011). 
Additionally, the mammalian nuclear envelope completely disintegrates and regenerates before 
and after cell division, further highlighting the dynamic nature of the ER. During nuclear 
envelope breakdown, the ER was found to lose interactions with microtubule plus-end binding 
proteins and enhanced binding to microtubule minus-end binding proteins (Schlaitz et al., 2013; 
Smyth et al., 2012). This would cause the ER to migrate towards the spindle poles and has been 
proposed to prevent interference during chromosomal segregation. Thus, the dynamic nature of 
the nuclear envelope aid in cell division and maintain interactions with the cytoskeleton. 
The ER also makes extensive contact with the mitochondria at sites that are called 
mitochondria-associated membranes (MAM), which are important for lipid transfer, calcium 
signaling and apoptosis (Figure 1.1C) (Hayashi et al., 2009; Rusinol et al., 1994). The ER and 
mitochondria come in close proximity, 10-50 nm, which could allow the transfer of lipids to 
occur between the two membranes, in a vesicle independent manner (Csordas et al., 2006). The 
ER is primarily responsible for the synthesis of phospholipids and cholesterol (Figure 1.2) (van 
Meer et al., 2008). Although the ER is the site of cholesterol synthesis, it contains a low level of 
cholesterol. While not all ER localized lipid synthesis enzymes are found in the MAM, some are 
enriched at these locations. Lipids synthesized in the ER are dispersed throughout 
endomembranes by membrane vesicles and lipid transport proteins (van Meer et al., 2008). 
Enrichment of lipid synthesis enzymes and lipid transfer at the MAM is needed since 
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mitochondria are not part of the endocytic pathway, thus mitochondria would require a vesicle 
independent system to acquire the appropriate lipids. Additionally, the ER is unique in its lipid 
composition in that it is the only organelle that has a completely symmetrical distribution of 
lipids, unlike the plasma membrane and the endomembranes that have a preference for certain 
lipids between the different leaflets (Devaux and Morris, 2004). Thus the ER serves as a platform 
to create much of the lipids necessary for maintaining the endomembrane systems.  
The MAM also contains factors important for calcium homeostasis, which help maintain 
a three to four order of magnitude concentration gradient in the ER relative to the cytoplasm 
(Brini and Carafoli, 2009; Lewis, 2007). Members of the sarcoplasmic/endoplasmic reticulum 
calcium ATPase (SERCA) class of proteins primarily maintain this gradient. These ER 
membrane pumps are responsible for sequestering calcium from the cytoplasm and into the ER 
lumen. Humans possess three different SERCA proteins named SERCA1, SERCA2 and 
SERCA3, which have two, three and six splice variants, respectively (Brini and Carafoli, 2009). 
SERC2B is ubiquitously expressed and is the primary ER calcium pump in non-muscle tissue, 
thus SERCA2B is the Sisyphus of the ER, forever tasked with the laborious task of pumping 
calcium from the cytoplasm into the ER lumen against the concentration gradient.  
Calcium can be released from the ER into the cytoplasm by stimulation of inositol 
triphosphate (IP3) receptors by various signaling pathways (Patterson et al., 2004; Zalk et al., 
2007). While IP3 receptors are found throughout the smooth ER, their localization at the MAM 
ensures efficient transfer of calcium from the ER into the mitochondria. Extra calcium in the 
mitochondria initially enhances ATP production; however, prolonged calcium influx into the 
cytoplasm or mitochondria will activate apoptotic signals (Hajnoczky et al., 2006; Hayashi et al., 
2009). Thus, the calcium flux must be promptly stopped upon activation to prevent toxic build up 
of cytoplasmic calcium. While SERCA2B is the main pump responsible for sequestering calcium 
into the ER, calcium can also be sequestered into the Golgi or mitochondria by Secretory 
8 
 
Pathway Ca2+-ATPase (SPCA) proteins or by the mitochondrial calcium uniporter (MCU), 
respectively (Brini and Carafoli, 2009; Hayashi et al., 2009). Excess calcium can also be cleared 
from the cytoplasm by expulsion into the extracellular space by Na
+
-Ca
2+
 exchangers located at 
the plasma membrane. Thus, the eukaryotic cell has adopted multiple ways of avoiding chronic 
elevation of cytoplasmic calcium levels. 
Calcium homeostasis is regulated by posttranslational events such as oxidation of 
disulfide bonds in either SERCA2B or the IP3 receptor by ER oxidoreductases (Higo et al., 2005; 
Li and Camacho, 2004). The formation of these disulfides is believed to lock the IP3 receptor and 
SERCA2B in a confirmation that inhibits release or sequestering of calcium, respectively. The 
activity of SERCA2B is also influenced by interactions with the lectin chaperone calnexin and the 
phosphorylation or palmitoylation status of calnexin (Lynes et al., 2013; Roderick et al., 2000). 
Finally and perhaps more drastically, the IP3 receptor can be targeted for ERAD shortly after 
stimulation to prevent excess release of ER calcium (Lu et al., 2011). These data demonstrate the 
multiple levels of calcium regulation, including compartmentalization, palmitoylation, 
phosphorylation, oxidation and protein degradation that a eukaryotic cell employs to modulate 
calcium homeostasis.  
The ER also comes in close contact (10-25 nm) with the plasma membrane in regions 
called the plasma membrane-associated membranes (PAM) (Figure 1.1C). Similar to the MAM, 
PAM is important for sterol transfer, lipid synthesis and calcium signaling (Pichler et al., 2001; 
Yeromin et al., 2006). When ER calcium levels become low, a calcium-sensitive ER membrane 
protein oligomerizes and moves toward the plasma membrane where it stimulates influx of 
extracellular calcium into the cytoplasm through a plasma membrane calcium channel (Roos et 
al., 2005). The elevated cytoplasmic calcium is then quickly sequestered by SERCA2B into the 
ER, thus extracellular calcium can be quickly targeted to the ER with minimal dwell time in the 
cytoplasm (Lewis, 2007). Additionally, work conducted in yeast indicates that endocytosis only 
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occurs in regions of the plasma membrane devoid of PAM, since PAM could interfere with 
retrograde trafficking (Stradalova et al., 2012).   
Parts of the smooth ER membrane are used to form peroxisomes at specific ER sub-
domains named pre-peroxisomal compartments (Figure 1.1C) (Tabak et al., 2013). Peroxisomes 
are disperse eukaryotic organelles with multiple metabolic functions, primarily beta-oxidation of 
long chain fatty acids. Though the exact molecular events of peroxisomal formation are unclear, it 
is known that multiple peroxisome proteins are originally targeted to the ER, and after some 
unknown cue, vesicles loaded with peroxisomal proteins bud off from the smooth ER to form 
mature peroxisomes (van der Zand et al., 2010; Yonekawa et al., 2011). In summary, a growing 
body of work implies that the ER is compartmentalized into multiple sub-domains, each 
dedicated to unique functions. 
Tetratricopeptide repeats, a resourceful adapter motif. 
A multitude of cellular functions rely on adapter proteins to mediate multi-protein 
complexes and aid in compartmentalization. By utilizing adapter proteins, the cell can increase 
the local concentration of specific factors without having to increase the total amount of the 
protein (Good et al., 2011). One such example is the ERQC, which is organized by SEL1L; the 
ER membrane adapter protein that nucleates a protein complex important for disposal of 
misfolded secretory proteins. Specifically, SEL1L utilizes ER luminal tetratricopeptide repeats 
(TPR) motifs to mediate the multi-protein ERQC complex consisting of both ER luminal and 
membrane proteins.  
TPR motifs consist of 34 amino acids that fold into two anti-parallel α helices with a 
short loop connecting the two helices (Figure 1.3A) (D'Andrea and Regan, 2003; Zeytuni and 
Zarivach, 2012). The consensus sequence for a TPR motif is degenerate. While no amino acid is 
absolutely conserved, there tends to be a propensity for some amino acids at certain positions 
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forming a delicate jigsaw puzzle wherein opposing amino acid side chains have evolved to 
complement each other (Main et al., 2003). Likely due to its small size, a single TPR motif is 
insufficient to form a functional unit, hence TPR domains are always found in a sequential 
organization to form functional clusters of individual TPR motifs. A minimum of three sequential 
TPR motifs form a functional cluster, but as many as sixteen have been predicted in an open 
reading frame in archaea (D'Andrea and Regan, 2003). Clusters of three TPR motifs are also the 
most common organization. Additionally, each cluster of TPR domains is followed by a C-
terminal capping helix needed for structural support or stability (Figure 1.3B). The sequential 
organization of TPR motifs creates a concave groove for the ligand and a convex backside needed 
for structural integrity (Figure 1.3C). While clusters of three to four TPR motifs tend to bind to a 
well-defined ligand, proteins with five or more sequential TPR motifs appear to be more 
promiscuous in their binding partners, with no clear consensus sequence among its substrates 
(Gatto et al., 2000; Lazarus et al., 2011; Scheufler et al., 2000). Thus, despite being a relatively 
simple motif, the number and organization of the TPR motifs can greatly influence scaffolding 
abilities and give them the ability to bind to a wide range of ligands.  
TPR domains exhibit a high degree of variability in their sequence and bioinformatic 
results have shown that certain positions are more variable than others, the so called 
hypervariable positions (Magliery and Regan, 2005). Interestingly, these hypervariable positions 
coincide with the amino acids that are important for recognizing the ligand in the structures of 
various TPR domains co-crystalized with their ligands (Gatto et al., 2000; Scheufler et al., 2000). 
Furthermore, mutating these hypervariable positions in a cluster of TPR motifs affects the binding 
specificity without affecting protein folding (Jackrel et al., 2009). This demonstrates that TPR 
motifs are highly moldable scaffolds, which can accommodate a wide range of ligands. 
The best-studied TPR domain containing protein is Hop (Hsp70-Hsp90 Organizing 
Protein), which possesses nine TPR domains in three separate clusters of three TPR motifs 
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(Figure 1.4 A) (Smith et al., 1993). The N-terminal TPR cluster of Hop recognizes the C-terminus 
of Hsp70 while the middle TPR cluster associates with the C-terminus of Hsp90, and the last 
cluster does not appear to bind a distinct ligand (Figure 1.4A). By bringing Hsp70 and Hsp90 
together in a complex, Hop facilitates the transfer of substrates from Hsp70 to Hsp90 (Chen and 
Smith, 1998a; Johnson et al., 1998). Both the N-terminal and middle clusters of TPR motifs 
recognize the C-terminal cytoplasmic EEVD tail of Hsp70 and Hsp90, respectively, implying that 
the EEVD sequence cannot be the sole determinant for selectivity (Brinker et al., 2002; Scheufler 
et al., 2000). The interactions between the clusters of TPR motifs in Hop and their respective 
ligands are mediated by both the side chain and the peptide backbone of the EEVD ligand. A 
synthetic heptamer peptide corresponding to the C-terminus of Hsp90 showed a clear preferential 
binding to the central TPR cluster of Hop as compared to the TPR cluster that is designated to 
interact with Hsp70 (Scheufler et al., 2000). Thus, the TPR domains of Hop can support proper 
chaperone interactions to create a multi-protein complex to assist with protein folding. While 
some TPR containing proteins like Hop have well-defined ligands for their TPR domains, others 
appear more promiscuous in selecting binding partners. 
O-linked β-N-acetylglucosamine transferase (OGT) possesses thirteen predicted TPR 
motifs ordered in a sequential manner and utilizes TPR motifs to recognize substrates for 
attachment of N-acetyl glucosamine to the side chains of serines or threonines (Figure1.4 B) (Iyer 
and Hart, 2003; Kreppel and Hart, 1999). Addition of N-acetyl glucosamine to client proteins has 
been shown to be important for the nuclear import of proteins as well as sensing cellular glucose 
levels (Hart et al., 2007). Of the thirteen predicted TPR motifs in OGT, eleven were solved in a 
crystal structure in the presence of a peptide ligand; however, the ligand crystallized with the 
catalytic domain instead of the TPR motifs (Jinek et al., 2004; Lazarus et al., 2011). While no 
consensus sequence among the ligands has been observed, it has been speculated that the TPR 
domains keep the substrate in a unfolded conformation in order to present the substrate to the 
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catalytic domain of the OGT. Hop and OGT highlight a trend among adapter proteins with TPR 
domains, wherein stretches of three to five sequential TPR motifs tend to recognize a shorter and 
more defined ligands whereas a higher number of sequential TPR motifs is less specific in their 
binding.  
The difference in ligand preference between shorter and longer clusters of TPR motifs is 
exhibited in Tom70, which uses a cluster of three TPR domains to interact with the C-terminal 
EEVD tail sequence of Hsp70 and a cluster of seven TPR motifs interacts with proteins targeted 
for mitochondrial import (Figure 1.4 C) (Wu and Sha, 2006; Young et al., 2003). Similarly to 
OGT, no clear mode of interaction has been described between a client protein and the large TPR 
cluster. Yet another similarity between Tom70 and OGT is that both appear to form homodimers 
using interactions with the convex backside of the their TPR domains (Jinek et al., 2004; Wu and 
Sha, 2006; Young et al., 2003). Similarly, Toc64 and Pex5 recognize the C-terminal EEVD of 
Hsp90 or the C-terminal SKL tag used for peroxisomal import (Gatto et al., 2000; Qbadou et al., 
2006). Thus TPR domains are versatile adapters that can be modulated to interact with a specific 
ligand or a broad range of substrates.  
TPR motifs appear to be used by proteins involved in post-translational translocation into 
mitochondria (tom70), chloroplast (Toc64) and peroxisomes (Pex5) (Chan et al., 2006; Gatto et 
al., 2000; Qbadou et al., 2006). Additionally, Saccharomyces cerevisiae contains the TPR protein 
Sec72p, which aids in post-translational translocation of proteins into the ER (Feldheim and 
Schekman, 1994; Jermy et al., 2006). The observation that TPR domains are found at sites of 
posttranslational protein translocation across cellular membranes could reflect the fact that 
translocation events are complicated processes and multiple proteins are needed to ensure the 
fidelity of this process and that substrates generally need to be unstructured to be translocated. 
TPR domains are excellent candidates for nucleating the necessary factors of protein translocation 
into a functional complex, and maintain the substrate in a translocation competent state.   
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To date only a few TPR domain-containing proteins have been localized to the ER, these 
are Sec72p, ERdj6 and SEL1L. Sec72p is an ER membrane proteins with three predicted 
cytoplasmic TPR motifs, which are believed aid in the posttranslational translocation of proteins 
targeted to the ER (Plath et al., 1998). While conflicting data have been published on the 
topology and function of ERdj6, recent work indicates that ERdj6 is an ER membrane protein 
with nine TPR motifs and a J-domain facing the ER lumen (Oyadomari et al., 2006; Rutkowski et 
al., 2007). ERdj6 has been shown to bind misfolded through the TPR domain whereas the J-
domain was important for recruiting BiP (Petrova et al., 2008). SEL1L is a type I ER membrane 
protein that possesses eleven TPR domains in three separate clusters of four, five and two TPR 
motifs, respectively (Figure 1.4 D). Degradation of a variety of misfolded proteins depended on 
SEL1L (Mueller et al., 2006). SEL1L is an important converging point in ERAD, as it facilitate 
formation of a multi-protein membrane complex and mediates interactions with proteins in the 
ER lumen (Christianson et al., 2008; Cormier et al., 2009; Hosokawa et al., 2008; Iida et al., 
2011; Mueller et al., 2008). Interestingly, SEL1L retained its interaction with luminal binding 
partners when the transmembrane domain was removed, implying that a luminal TPR domain 
containing portion of SEL1L is sufficient to mediate protein-protein interactions with the soluble 
quality control receptors, EDEM1, OS-9 and XTP3-B (Christianson et al., 2008). All together, the 
degenerate nature of TPR motifs can be utilized to nucleate a host of protein complexes for 
various functions across multiple organelles, although only a few have been localized to the ER.  
A bioinformatics screen for novel TPR containing ER adapter proteins 
The ER appears to have a high-level of organization, and ER-resident adapter proteins 
contribute to this organization by nucleating large multi-protein complexes. Mammalian cells 
have ~180 predicted TPR domain containing proteins, and one-third of the proteome is targeted 
to the ER (Letunic et al., 2012). Therefore, we hypothesized that there might be novel 
uncharacterized ER adapter proteins that utilize TPR motifs to aid in the compartmentalization 
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and organization of ER processes. To explore this possibility further, we acquired a partial in 
silico TPR protein library from Dr. L. Regan, (Magliery and Regan, 2005) (Figure 1.5). This 
partial TPR protein library contains ~ 300 proteins from a variety of organisms and was created at 
random to perform bioinformatic studies on TPR domain proteins. The amino acid sequence of 
proteins within the library was subjected to a signal sequence prediction algorithm to predict 
whether any of these proteins were likely to be targeted to the ER via an N-terminal signal 
sequence (Bendtsen et al., 2004). It should be noted that proteins that are targeted to the ER 
independent of a N-terminal signal sequence would be missed using this approach (Johnson et al., 
2013).  
NASP (Nuclear autoantigenic sperm protein) and TMTC1 (Transmembrane and TPR 
repeat-containing protein 1) were two original hits discovered with this search (Figure 1.6). While 
NASP has been linked to histone assembly in the nucleus, TMTC1 was completely 
uncharacterized (Batova and O'Rand, 1996; Finn et al., 2012). The original two hits were further 
expanded using BLAST searches to identify additional uncharacterized TPR containing proteins 
with a predicted N-terminal ER targeting sequence. This approach identified seven additional 
putative secretory TPR proteins named TMTC2, TMTC3, TMTC4, TTC9B, TTC13, TTC17, and 
TTC35. This in silico screen scheme expanded our results to nine putative secretory adapter 
proteins that contain TPR domains (Figure 1.6).  
Multiple TPR containing adapter proteins are anchored in a membrane, and membrane 
insertion can greatly enhance the ability of adapter proteins to nucleate protein complexes by 
restricting their diffusion to two dimensions. Thus, all nine proteins identified in our screen were 
also analyzed using the ΔG prediction software, which predicts the free energy of inserting a 
hydrophobic domain into a membrane (Hessa et al., 2007). While TMTC1-4 were predicted to 
have various numbers of transmembrane domains, TTC9B, TTC13, TTC17, TTC35 and NASP 
were all predicted to be soluble proteins. Taken together, we have discovered nine putative 
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adapter proteins that possess multiple TPR motifs and appear to be targeted to the ER by N-
terminal signal sequences. The biochemical and cell biological characterization of these nine 
proteins will allow us to determine if they are targeted to the ER, reside in the ER and act as 
adapter proteins to nucleate large protein complex formation that are used to organize functional 
complexes. 
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Figure 1.1 Organization of the endoplasmic reticulum. 
 
(A) Cos7 cells were stained for ERp57 as a marker for the endoplasmic reticulum (ER). The 
staining highlights how the ER surrounds the nuclear envelope and extends throughout the cell. 
(B) The ER can be divided into three major domains termed the nuclear envelope, sheets and 
tubules. (C) ER is in close contact with other organelles through specialized sub-domains of the 
ER such ER exist sites (ERES), mitochondria associated membranes (MAM), plasma membrane-
associated membranes (PAM) and the pre-peroxisomal compartments.   
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Figure 1.2 The endoplasmic reticulum functional compartmentalization.  
 
The first identified sub-domain of the ER was the rough ER (RER), which is enriched in factors 
needed for co-translational translocation into the ER and early protein folding and modification 
events. The ER is also the site of synthesis for the bulk of the phospholipids and cholesterol and 
hosts many enzymes important for lipid synthesis (blue), and flippases (green and gray) in the ER 
membrane. The majority of the intracellular calcium is stored in the ER, where SERCA2B 
(green) is the primary pump to sequester calcium into the ER and inositol trisphosphate receptor 
(pink and purple) stimulation causes release of calcium from the ER. Properly folded secretory 
proteins are targeted to the ER exit sites (ERES), where cargo is packaged into COPII covered 
vesicles (blue ovals) for sorting to the ER-Golgi-intermediate compartment then the Golgi. Due to 
the inherent difficulties of protein folding, a portion of secretory proteins fail to reach their native 
state and must be degraded to prevent toxic build up of misfolded proteins. The ER quality 
control compartment (ERQC) utilizes a membrane embedded adapter protein (SEL1L, red) to 
nucleate a multi protein complex that can efficiently dispose of misfolded proteins. The overall 
health of the ER is monitored by the unfolded protein response (UPR), which senses 
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accumulation of misfolded proteins or other stress signals and launches a stress response to 
restore ER homeostasis.  
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Figure 1.3 Tetratricopeptide repeats as adapter motifs. 
 
 (A) Tetratricopeptide repeats (TPR) are structural motifs that consist of 34 amino acids and fold 
into two helices (PDB# 1ELR). Sequential TPR motifs create a functional domain. The crystal 
structure represents one of the TPR motifs of Hsp70/Hsp90-organizing protein (Hop) (Scheufler 
et al., 2000). (B) The different TPR motifs of Hop are color coded blue, purple and cyan, with 
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ligand binding residues colored red. The capping helix is pale blue and the Hsp90 ligand is 
designated in green. (C) Structure as in B tilted 90 degrees towards the reader. 
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Figure 1.4 Various TPR domain adapter proteins found in eukaryotic cells.  
 
(A) Hop is an adapter protein that mediates the interaction between Hsp70 and Hsp90, thereby 
facilitating the transfer of substrates from one chaperone to the other (Chen and Smith, 1998b; 
Johnson et al., 1998). (B) O-linked β-N-acetylglucosamine transferase uses thirteen sequential 
TPR domains to prepare client proteins for O-linked glycosylation (Iyer and Hart, 2003; Kreppel 
and Hart, 1999). (C) TOM70 is a TPR domain containing protein that utilizes one cluster of TPR 
domains for Hsp70 docking and a second larger cluster for client proteins to be translocated (Wu 
and Sha, 2006; Young et al., 2003). (D) SEL1L utilizes both asparagine (N)-linked glycans and 
TPR domains to nucleate a multi-protein complex needed for endoplasmic reticulum-associated 
degradation (ERAD) in the ERQC sub-domain (Avezov et al., 2008; Christianson et al., 2008; 
Cormier et al., 2009; Hosokawa et al., 2008).   
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Figure 1.5 Bioinformatics strategy to identify novel ER adapter proteins. 
 
An in silico library of known TPR proteins was a generous gift from Dr. Lynne Regan at Yale 
University (Magliery and Regan, 2005). The library of TPR proteins was analyzed with SignalP 
3.0, a software that predicts N-terminal signal sequences (Bendtsen et al., 2004). The original hits 
were further expanded by BLAST searches and other in silico methods to generate a larger list of 
proteins containing TPR domains and predicted ER targeting sequences (Altschul et al., 1990). 
Finally, identified proteins were analyzed with ∆G predictor, a software that predicts 
transmembrane domains (Hessa et al., 2011).  
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Figure 1.6 Putative ER adapter proteins.  
 
Our screen for novel secretory adapter proteins identified nine putative TPR-containing proteins 
that were potentially targeted to the ER by an N-terminal signal sequence (black squares). The 
names, position of tetratricopeptide repeat (TPR) (red rectangles), hydrophobic domains (green 
squares), asparagine (N)-linked glycans (black branched structures), proline-rich domains (blue 
squares) and histone binding domains (brown rectangles) are designated.   
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CHAPTER II 
 
TMTC1 AND TMTC2 ARE REGULATORS OF CALCIUM HOMEOSTASIS. 
 
Abstract 
The endoplasmic reticulum (ER) is organized in part by adapter proteins that nucleate the 
formation of large protein complexes. Tetratricopeptide repeats (TPR) are well-studied protein 
structural motifs that support intermolecular protein-protein interactions. TMTC1 and TMTC2 
were identified by an in silico search as TPR containing proteins possessing N-terminal ER 
targeting signal sequences and multiple hydrophobic segments, suggestive of polytopic 
membrane proteins that are targeted to the secretory pathway. A variety of cell biological and 
biochemical assays were employed to demonstrate that TMTC1 and TMTC2 are both ER resident 
integral membrane proteins with multiple clusters of TPR domains orientated within the ER 
lumen. Proteomic analysis followed by co-immunoprecipitation verification found that both 
proteins associated with the ER calcium uptake pump SERCA2B, while TMTC2 also bound to 
the carbohydrate-binding chaperone calnexin. Live cell calcium measurements revealed that 
overexpression of either TMTC1 or TMTC2 caused a reduction of calcium released from the ER 
following stimulation, whereas the knockdown of TMTC1 or TMTC2 increased stimulated 
calcium released. Together, these results implicate TMTC1 and TMTC2 as ER proteins involved 
in calcium homeostasis. 
Introduction 
The endoplasmic reticulum (ER) is an organelle comprised of a continuous membrane-
envelope and lumen that is compartmentalized into numerous functional regions (Voeltz et al., 
2002). The organization of the ER is directed in part by extrinsic factors that organize the rough 
ER (ribosomes) and the contiguous nuclear envelope (lamina and lamina receptors), as well as 
through interactions with the cytoskeleton (microtubules), organelles (Golgi and mitochondria) or 
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the plasma membrane (Levine and Rabouille, 2005). ER resident adapter proteins that nucleate 
the formation of large protein complexes also support the compartmentalization of the ER 
(Carvalho et al., 2006; Christianson et al., 2008; Mueller et al., 2008). The organization of the ER 
contributes to its ability to efficiently perform functions in the maturation, quality control and 
trafficking of secretory pathway cargo, calcium regulation and lipid synthesis (English et al., 
2009; Hebert and Molinari, 2007; Lynes et al., 2013). These activities contribute to the 
maintenance of general cellular homeostasis; however, many questions still remain as to how the 
organization of the ER is maintained. 
Tetratricopeptide repeats (TPR) are protein structural motifs that support protein-protein 
interactions. A single TPR domain consists of a degenerate 34 amino acid sequence that is 
comprised of two anti-parallel helices (D'Andrea and Regan, 2003; Das et al., 1998). A minimum 
of three consecutive TPR domains is required to form a functional unit, and this is the most 
common number of TPR found in a cluster (D'Andrea and Regan, 2003). Clusters comprised of 
up to sixteen sequential TPR have been observed. Proteins with three TPR domains in a cluster 
favor the recognition of short and defined sequences, whereas proteins with long stretches of 
consecutive TPR domains tend to be more promiscuous in their selectivity. For example, the 
Hsp70-Hsp90 Organizing Protein (HOP) uses two separate clusters of three consecutive TPR 
domains to bind the EEVD sequence located at the C-termini of Hsp70 and Hsp90, facilitating the 
hand-off of a substrate from one chaperone to another (Chang et al., 1997; Scheufler et al., 2000). 
In contrast, the O-linked N-acetylglucosamine transferase possesses twelve consecutive TPR 
domains that are proposed to bind and prepare substrates for modification (Lazarus et al., 2011). 
Tom70 displays a combination of TPR clusters as it uses a cluster of three TPR domains to 
recognize the C-terminus of Hsp70 for substrate delivery and a second cluster of seven TPR 
domains to potentially prepare substrates for mitochondrial import (Wu and Sha, 2006). These 
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diverse cellular functions are coordinated by TPR domains and their ability to bind to a range of 
ligands. 
SEL1L and p58IPK (also called ERdj6) are the only ER TPR containing proteins that 
have been characterized in mammalian cells. SEL1L nucleates a large ER membrane complex 
involved in ER-associated degradation (ERAD) (Mueller et al., 2008). p58IPK is an ER co-
chaperone that interacts with BiP to facilitate protein folding (Petrova et al., 2008; Rutkowski et 
al., 2007). Given the extensive utilization of TPR domains in metazoans to support protein-
protein interactions, the ER is expected to contain additional TPR domain proteins that contribute 
to complex formation and ER organization.  
An in silico approach was used to expand our understanding of ER adapters that 
participate in the organization of the ER using TPR domains. TMTC1 and TMTC2 were 
identified as TPR containing proteins that possess potential N-terminal ER targeting sequences 
and multimembrane spanning regions. They were both found to reside in the ER membrane with 
their TPR domains orientated within the ER lumen. A role for TMTC1 and TMTC2 as adapter 
proteins was supported by their appearance in large molecular weight complexes. A shotgun 
proteomics approach was employed that identified SERCA2B as a potential binding partner for 
TMTC1 and TMTC2, as well as calnexin for TMTC2. Manipulation of the expression levels of 
TMTC1 and TMTC2 combined with live cell calcium measurements demonstrated that TMTC1 
and TMTC2 influenced calcium sequestering in the ER. Collectively, these findings showed that 
TMTC1 and TMTC2 are two novel TPR containing ER adapters involved in calcium 
homeostasis. 
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Results 
 TMTC1 and TMTC2 are ER resident proteins.  
As adapter proteins commonly use clusters of TPR domains to modulate protein-protein 
interactions, we hypothesized that the ER might contain TPR domain-containing proteins, in 
addition to SEL1L and p58IPK that contribute to the organization of the ER. Databases 
(SMART7 (Letunic et al., 2012)) and a Regan lab TPR protein library (Yale University) 
(Magliery and Regan, 2005) were queried with SignalP 3.0 to identify TPR proteins that were 
potentially targeted to the secretory pathway (Bendtsen et al., 2004). TMTC1 (Transmembrane 
and TPR repeat-containing protein 1 (NCBI Accession # NP_787057.2 
(http://www.ncbi.nlm.nih.gov/protein/NP_787057.2)) and TMTC2 (NCBI Accession # 
NP_689801.1 (http://www.ncbi.nlm.nih.gov/protein/NP_689801.1)) were identified as TPR-
containing proteins with potential N-terminal signal sequences. These proteins were initially 
identified, but not characterized, in a large human sequencing study that identified opening 
reading frames from human cells (Gerhard et al., 2004; Ota et al., 2004). In silico analysis of 
TMTC1 and TMTC2 indicated that each protein contained a potential N-terminal signal sequence 
and ten C-terminal TPR domains (Figure 2.1A).  
Two TMTC1 isoforms are reported in the NCBI Protein Database with NCB Accession # 
NP_001180380.1 (http://www.ncbi.nlm.nih.gov/protein/NP_001180380.1) and NP_787057.2 
(http://www.ncbi.nlm.nih.gov/protein/NP_787057.2), for isoform 1 and 2 respectively (Sayers et 
al., 2009). TMTC1 splice variants present in HEK293T cells were determined by PCR using 
isoform specific primers on a cDNA library generated from total mRNA. A PCR product was 
observed using the primers directed against regions of the TMTC1 isoform 2, while a product was 
not generated for isoform 1 (Figure 2.1B and C). qRT-PCR using a variety of primer sets failed to 
amplify a PCR product that would correlate with TMTC1 isoform 1. As only the TMTC1 isoform 
2 was expressed in HEK293T cells, this isoform will be referred to as TMTC1. 
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TMTC1 and TMTC2 cDNAs were subcloned into mammalian expression vectors 
encoding a C-terminal myc-tag, and their cellular localization was determined by confocal 
immunofluorescence microscopy. COS7 cells were transfected with either TMTC1-myc or 
TMTC2-myc, and staining was compared against an ER (ERp57) or Golgi (GM130) marker 
(Figure 2.2A). Both TMTC1 and TMTC2 colocalized with ERp57, while colocalization was not 
observed with GM130, suggesting that TMTC1 and TMTC2 are both ER resident proteins.  
Secretory proteins are commonly modified in the ER with N-linked glycans at the 
consensus site Asn-X-Ser/Thr. TMTC1 and TMTC2 both possess a single N-linked glycosylation 
consensus site (Figure 2.1A), therefore a glycosylation assay was used to further analyze ER 
targeting and localization. As the molecular weight of an N-linked glycan is ~2.5 kD, the removal 
of N-linked glycans by glycosidase treatment results in a corresponding increase in mobility for 
the deglycosylated protein. Endoglycosidase H (Endo H) trims the high mannose glycans 
encountered in the ER while Peptide-N-Glycosidase F (PNGase F) removes complex glycans 
acquired in the Golgi in addition to high mannose glycans.  
HEK293T cells transfected with TMTC1 or TMTC2 containing a C-terminal S-tag were 
pulsed with [35S]-Met/Cys for 60 min. Cell lysate and media fractions were affinity precipitated 
with S-protein agarose beads followed by glycosidase treatment. Shifts upon glycosidase 
treatment were not observed for either TMTC1 or TMTC2 indicating that neither protein 
appeared to be glycosylated (Figure 2.2B). As not all glycosylation sites are efficiently 
recognized and modified, two N-linked glycosylations sites were introduced to the C-terminal 
portion of TMTC1 (TMTC1
N626, 633
) and TMTC2 (TMTC2
N602, 818
)(Figure 2.1A, see asterisks). 
These constructs migrated slower than the wild type constructs, and their treatment with PNGase 
F produced faster migrating proteins indicating that TMTC1
N626, 633 
and TMTC2
N602, 818 
were both 
modified with N-linked glycans (Figure 2.2C). A similar increase in mobility was observed upon 
Endo H treatment indicating that the carbohydrates were high mannose glycoforms. Therefore, 
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the cellular distribution for TMTC1 and TMTC2 and the glycosylation profiles for the glycan 
addition mutants are consistent with TMTC1 and TMTC2 residing in the ER. 
 TMTC1 and TMTC2 are upregulated by oxidative stress.  
Proteins that reside in the secretory pathway are frequently transcriptionally upregulated 
by stress as their functions can help to alleviate stress (Walter and Ron, 2011). To determine 
whether the TMTC1 and TMTC2 genes are transcriptionally regulated by ER stress, HEK293T 
cells were exposed to different ER stress conditions. Cells were subjected to oxidative stress 
(dithiotreitol, DTT), calcium depletion (thapsigargin), N-glycan synthesis inhibition 
(tunicamycin) or amino acid starvation (-Cys/Met). RNA was harvested from cells followed by 
reverse transcription to generate cDNA and changes in gene expression were measured by qRT-
PCR. TMTC1 and TMTC2 gene expression was increased with DTT treatment by 3.9 and 2.3 
fold, respectively (Figure 2.3). However, thapsigargin, tunicamycin or amino acid starvation did 
not produce a significant increase in gene expression of TMTC1 or TMTC2, although the 
transcription of BiP was significantly stimulated by DTT, thapsigargin and tunicamycin. Thus, 
only oxidative stress increased the transcription of TMTC1 and TMTC2.  
 TMTC1 and TMTC2 are ER membrane proteins with luminal orientated TPR 
domains.  
Analysis of the TMTC1 and TMTC2 protein sequences with ΔG prediction demonstrated 
that TMTC1 and TMTC2 contained 9 and 10 hydrophobic segments, respectively, that could 
potentially serve as transmembrane domains to create polytopic membrane proteins (Figure 2.1A) 
(Hessa et al., 2007). Alkaline extraction of membrane fractions was performed to separate 
membrane and soluble forms of proteins following centrifugation to determine if TMTC1 and 
TMTC2 are integral membrane proteins (Giorda et al., 2012; Mostov et al., 1981).   
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HEK293T cells were transfected with either TMTC1 or TMTC2, and proteins were 
radiolabeled with [
35
S]-Met/Cys for 60 min. Cells were homogenized in isotonic buffer and 
fractions were separated by centrifugations. TMTC1 and TMTC2 were found in the total 
membrane and nuclear fractions (Figure 2.4A). The nuclear localization of TMTC1 and TMTC2 
is likely explained by the contiguous nature of the ER and nuclear membrane prohibiting their 
separation as the ER proteins calnexin and calreticulin were also in the nuclear fractions. Alkaline 
extraction of the total membrane fractions followed by centrifugation found TMTC1 and TMTC2 
exclusively in the membrane pellet. This profile was observed for the ER membrane protein 
calnexin and not its soluble paralogue calreticulin, which largely accumulated in the supernatant. 
Therefore, both TMTC1 and TMTC2 are integral membrane proteins. 
Since TMTC1 and TMTC2 are membrane proteins, a trypsin protection assay was 
employed to determine if their C-terminal TPR domains are positioned in the ER lumen or the 
cytoplasm. HEK293T cells were transfected with either TMTC1 or TMTC2 constructs containing 
C-terminal S-tags and pulsed with [35S]-Met/Cys for 60 min followed by homogenization and 
isolation of ER-enriched microsomes. Isolated microsomes were resuspended in an isotonic 
buffer, and aliquots were treated with Triton-X 100 and trypsin as indicated. Affinity purification 
using S-agarose beads allowed the isolation of proteins containing a protected C-terminus. 
Trypsin treatment produced discrete TMTC1 and TMTC2 fragments of 62.5 and 51.6 kD, 
respectively (Figure 2.4B, compare lanes 5 to 6 and 9 to 10). As the TPR domains and S-tags are 
both at the C-termini, this demonstrated that the TPR domains of TMTC1 and TMTC2 were 
positioned in the ER lumen. Combined with the modification of the glycosylation sites added to 
the TPR rich regions (Figure 2.2C), these results demonstrated that the TPR domains for both of 
the membrane proteins TMTC1 and TMTC2 were facing the ER lumen. 
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 TMTC1 and TMTC2 associate with SERCA2B.  
To identify binding partners of TMTC1 and TMTC2, a shotgun liquid chromatography-
mass spectrometry/mass spectrometry (LC-MS/MS) approach was used. Cells expressing either 
TMTC1 or TMTC2 with a C-terminal S-tag were homogenized and ER-derived microsome 
fractions were isolated. Proteins associated with TMTC1and TMTC2 were isolated using the S-
protein agarose beads and resolved by SDS-PAGE. The gels were subjected to either silver 
staining or in-gel trypsin digestion followed by LC-MS/MS analysis (Figure 2.5A). The proteins 
associated with the S-tagged proteins obtained from the LC-MS/MS analysis were scored 
according to the number of unique peptides identified from the corresponding protein (Table 2.1). 
The top four associated proteins for TMTC1 and TMTC2 were identical: SERCA2B, calnexin, 
BiP and the glucosidase II α subunit. 
To verify the interactions identified using the mass spectrometry approach, HEK293T 
cells were transfected with the C-terminal S-tagged TMTC1 or TMTC2, followed by affinity 
purification and immunoblotting against endogenous associated proteins. Both TMTC1 and 
TMTC2 readily interacted with SERCA2B, a polytopic ER calcium pump responsible for calcium 
uptake from the cytoplasm into the ER (Figure 2.5B). TMTC2, but not TMTC1, interacted with 
calnexin. Calnexin is a carbohydrate-binding chaperone of the ER membrane that associates with 
maturing glycoproteins that possess monoglucosylated glycans (Pearse and Hebert, 2010). The 
TMTC2-calnexin interaction appeared to be specific since TMTC2 did not interact with 
calreticulin, the soluble paralog of calnexin, or the calnexin-associated oxidoreductase ERp57 
(Figure 2.5B). The interaction between calnexin and TMTC2 was reduced though not abolished 
by glucosidase inhibition with N-butyl-deoxynojirimycin even though TMTC2 was not 
glycosylated (Figure 2.5C). These results suggested that an additional glycosylated component 
might be involved in TMTC2 binding to calnexin. Despite being identified by the mass 
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spectrometry results (Table 2.1), no interaction between TMTC1 and TMTC2 with either BiP or 
the glucosidase II α subunit was observed (Figure 2. 5B). 
To determine the approximate size of the TMTC1 and TMTC2 complexes, velocity 
centrifugation was performed. HEK293T cells were transfected with either S-tagged TMTC1 or 
TMTC2. Cells were lysed in Triton-X 100, and cell lysates were layered on a 10-40% linear 
sucrose gradient followed by centrifugation. TMTC1 and TMTC2 were exclusively found in the 
larger fractions indicating that both proteins resided in large protein complexes (Figure 2.5D, 
fractions 7-10). The SERCA2B sedimentation profile overlapped with the TMTC1 and TMTC2 
profiles, though SERCA2B was also found in lighter fractions absent of TMTC1 and TMTC2 
(Figure 2.5D, fractions 5 and 6). While calnexin was predominantly localized to smaller size 
fractions (Figure 2.5D, fractions 1-4), a portion was also observed in the TMTC1 and TMTC2 
fractions. Collectively, these results indicate that TMTC1 and TMTC2 are found in large protein 
complexes that include SERCA2B, as well as calnexin for TMTC2. 
To determine if the interactions with TMTC1 and TMTC2 involved their TPR domains, 
the C-terminal TPR rich portion of TMTC1 (TMC1
TPR
) and TMTC2 (TMTC2
TPR
) were targeted 
to the ER in HEK293T cells using the signal sequence of BiP and a C-terminal S-tag followed by 
an ER KDEL retention sequence to support ER residency. TMTC1
TPR
 and TMTC2
TPR
 were both 
efficiently targeted to and retained in the ER as observed by confocal immunofluorescence 
microscopy (Figure 2.6A) and the absence of the appearance of the constructs in the cell media 
(data not shown). TMTC1
TPR
 and TMTC2
TPR
 maintained their interaction with SERC2B, 
suggesting that these interactions were mediated through the TPR domains of TMTC1 or 
TMTC2. In contrast, TMTC2
TPR
 did not associate with calnexin, implying that this interaction 
required the transmembrane domain of TMTC2 (Figure 2.6B). Thus, the TPR domains of 
TMTC1 and TMTC2 were utilized to mediate the interactions with SERCA2B.  
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 TMTC1 and TMTC2 alter cytoplasmic calcium levels.  
As TMTC1 and TMTC2 both interact with SERCA2B, live cell calcium measurements 
were used to elucidate the impact of TMTC1 and TMTC2 on calcium regulation. Initially, 
cytoplasmic calcium levels were monitored after the overexpression of TMTC1 or TMTC2. 
Green fluorescent protein (GFP) was fused to the C-termini of TMTC1 (TMTC1
GFP
) and TMTC2 
(TMTC2
GFP
) to mark efficiently transfected cells for analysis (Figure 2.7A). Cells were incubated 
with Fura-2 AM, a membrane permeable fluorophore that is rendered membrane impermeable by 
cytoplasmic esterases. The treatment of cells with ATP and carbachol releases intracellular 
calcium stores, as carbachol is a non-cleavable acetylcholine analog that stimulates muscarinic 
receptors at the plasma membrane resulting in the downstream release of calcium from the ER via 
the inositol trisphosphate receptor (Luo et al., 2001; Wu et al., 2002). 
Cell expressing TMTC1
GFP
 or TMTC2
GFP
 and treated with ATP and carbachol showed 
calcium responses that reached peaked levels earlier than non-transfected cells (Figure 2.7B). 
Nevertheless, a 33.8%, 45.2% and 30.4% decrease in calcium release was observed in cells 
expressing either TMTC1
GFP
, TMTC2
GFP
 or both compared to non-transfected cells, respectively. 
These results suggest that TMTC1 and TMTC2 affect calcium homeostasis, possibly by 
modifying the calcium sequestering capacity of SERCA2B to decrease the duration of the 
calcium signal. No synergy between TMTC1 and TMTC2 was observed when both proteins were 
expressed together. 
Intracellular calcium release can also be stimulated by addition of calcium ionophores 
such as ionomycin, which promote release mostly from intracellular stores when the exposure is 
performed in the absence of extracellular calcium. Therefore, cells expressing TMTC1
GFP
 or 
TMTC2
GFP
, bathed in calcium free media and exposed to ionmycin had a 20.2% and a 27.4% 
reduction in calcium release, respectively (Figure 2.7C-D). This implies that intracellular calcium 
stores were reduced by overexpression of TMTC1
GFP
 or TMTC2
GFP
.  
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Next, the effect of TMTC1 or TMTC2 knockdown on cytoplasmic calcium levels was 
investigated. TMTC1 or TMTC2 was knocked down by transfecting HEK293T cells with a 
polycistronic plasmid that expressed an shRNA directed towards transcripts for either TMTC1 or 
TMTC2, as well as a cytoplasmic localized GFP to mark transfected cells. To verify knockdown 
efficiencies, RNA was harvested from HEK293T cells 24 hr post-transfection, and changes in 
gene expression were measured by qRT-PCR (Figure 2.8A). Fluorescence-activated cell sorting 
of GFP expressing cells was used to measure transfection efficiency of the different shRNA 
constructs. TMTC1 shRNA1 and TMTC2 shRNA3 achieved the maximum knockdown of 55% 
and 48%, respectively, in a cell mixture of transfected and non-transfected cells. These shRNA 
constructs were used for further analysis of effects on calcium measurements. Since cytoplasmic 
GFP was also expressed from the shRNA encoding plasmid, transfected and non-transfected cells 
were readily distinguishable by microscopy. Knockdown of either TMTC1, TMTC2 or both 
resulted in a 33.1%, 64.1% or 71.0% increase in carbachol stimulated ER calcium release, 
respectively (Figure 2.8B). While peak calcium levels were not greatly affected by knockdown of 
either molecule, calcium release was enhanced, especially after TMTC2 knockdown, which 
prolonged the response suggesting that it promoted greater calcium influx. Collectively, these 
results indicate that overexpression of TMTC1 or TMTC2 decreases stimulated calcium release, 
whereas their knockdown, especially for TMTC2 or both TMTC1 and TMTC2 combined 
enhanced calcium increases into the cytoplasm supportive of a role for TMTC1 and TMTC2 in 
calcium regulation. 
Discussion 
We identified and characterized two novel TPR-rich ER proteins, TMTC1 and TMTC2. 
They share a 54% similarity and 27% identity in the amino acid sequence, suggestive of a 
common evolutionary origin (Sievers et al., 2011). Basic Local Alignment Search Tool (BLAST) 
analysis indicated that TMTC1 and TMTC2 homologues are conserved in the chordata phylum 
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and are absent in lower eukaryotes such as yeast as is their most prominent associated protein 
SERCA2B (Brini and Carafoli, 2009). Published microarray data shows that TMTC1 and 
TMTC2 are transcribed in a wide range of human tissues (Wu et al., 2013). TMTC1 and TMTC2 
are divided into two regions that appear to create two functionally distinct domains, an N-
terminal hydrophobic region and a C-terminal domain that contains multiple TPR clusters (Figure 
2.1A).  
Alkaline extraction of total membrane preparations demonstrated that TMTC1 and 
TMTC2 are integral membrane proteins. ΔG analysis predicts that the N-termini of TMTC1 and 
TMTC2 have ten and eleven potential transmembrane domains, respectively. A negative ΔG 
associated with a high probability of membrane integration was calculated for five (TMTC1) and 
three (TMTC2) of these hydrophobic segments. Hydrophobic domains with a positive ΔG 
frequently insert into membranes upon stabilization by efficiently inserted transmembrane 
domains (Hessa et al., 2007). Therefore, TMTC1 and TMTC2 appear to be polytopic membrane 
proteins with their hydrophobic N-termini providing a long stretch of multiple transmembrane 
segments. The presence of a number of hydrophilic and charged residues within some of the 
hydrophobic domains of TMTC1 and TMTC2 imply that these residues could be used for 
intramembrane interactions, such as the TMTC2-calnexin interaction.  
The single natural N-glycosylation site present in the N-terminal hydrophobic portion of 
either TMTC1 or TMTC2 was not modified as probed by a glycosidase mobility shift assay. Lack 
of apparent glycosylation could be due to positioning of the consensus sites in the cytoplasm or 
being too close to the membrane for recognition by the oligosaccharyltransferase (Nilsson and 
von Heijne, 1993). Alternatively, the shift caused by glycosidase treatment and the removal of a 
single glycan might be too slight to be visualized for these large hydrophobic proteins. However, 
ER targeting was verified by placing efficiently modified glycosylation sites in the C-terminal 
TPR-rich regions of both TMTC1 and TMTC2 and by confocal immunofluorescence microscopy.  
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The glycosylation of sites added to the TPR regions of TMTC1 and TMTC2, combined 
with the trypsin protection of the C-terminal domains from isolated membranes, placed the TPR 
domains within the ER lumen for both TMTC1 and TMTC2. The trypsin protected fragments of 
63 kD (TMTC1) and 52 kD (TMTC2) corresponded to the complete C-terminal TPR domains 
(Figure 2.1A). UniProt predicted that TMTC1 has a total of ten TPR domains organized into 
clusters of seven and three, while TMTC2 has ten total TPR domains found in clusters of four and 
six. In contrast, analysis of TMTC1 by TPR domain prediction software TPRpred did not 
recognize the second and sixth TPR domains of TMTC1 as bona fide TPR domains. The space 
between the seventh and eighth TPR domains in TMTC1, which was not identified by UniProt, 
was predicted to be an additional TPR domain by TPRpred, UniProt and TPRpred predictions are 
in strong agreement for TMTC2. The only discrepancy between the analyses was that TPRpred 
did not recognize the first TPR motif of TMTC2. The differences in organization of the TPR 
domains of TMTC1 and TMTC2 could have implications for their functions. 
TPR domains are found in proteins across species and organelles, and participate in a 
plethora of activities including protein folding, post-translational modification, translocation and 
signal transduction. Clusters of TPR domains form discrete domains that nucleate protein-protein 
interactions (D'Andrea and Regan, 2003; Scheufler et al., 2000; Zeytuni and Zarivach, 2012). 
Sucrose sedimentation analysis suggested that both TMTC1 and TMTC2 resided in large 
molecular weight complexes. SERCA2B was the most prominent associated proteins for both 
TMTC1 and TMTC2, and this interaction was mediated through the TPR domains as the 
association persisted with a soluble construct comprised solely of the TPR-rich C-terminal region. 
The dependency of the TPR domains of TMTC1/TMTC2 for the interactions with SERCA2B 
was unexpected given the hydrophobic nature of TMTC1/TMTC2 and SERCA2B, and the small 
portion of SERCA2B that is exposed to the ER lumen. It cannot be ruled out at this time that the 
38 
 
TMTC1 or TMTC2 interaction with SERCA2B is mediate through an additional protein in the 
large complex. 
The carbohydrate-binding ER chaperone, calnexin, was also found to interact with the 
non-glycosylated TMTC2 but not TMTC1. Binding was reduced by 50% in the presence of 
glucosidase inhibition. Calnexin did not interact with the soluble TPR domain construct of 
TMTC2. The interaction could be mediated through the transmembrane segments of SERCA2B 
and calnexin (a type I membrane protein) as calnexin has been proposed to monitor proteins 
within the ER bilayer (Swanton et al., 2003). Alternatively, an additional glycosylated substrate 
such as SERCA2B may be involved in the interaction between TMTC2 and calnexin, as calnexin 
is known to associate with SERCA2B (Roderick et al., 2000). 
TMTC1 and TMTC2 overexpression reduced the amount of calcium released from the 
ER after stimulation with carbachol and ATP. This reduction might be caused by a decrease in 
total amount of calcium stored in the ER, implying a defect in calcium uptake and/or storage. 
This is consistent with the observed higher baseline calcium values, especially in cells 
overexpressing TMTC2. Elevated baselines and reduced calcium release was also seen in studies 
using ionomycin implying that overexpression of TMTC1 or TMTC2 disrupts calcium 
homeostasis in these cells. It is unclear how these proteins might interfere with calcium ER 
levels, although SERCA2B is likely a target, given the evidence of direct interaction between 
these two molecules.  
In contrast, knockdown of TMTC1 and TMTC2 caused an increase in the calcium 
response to the same agonists. While the amplitude of the peak response was not higher, it was 
longer, especially after TMTC2 knockdown. An interpretation of these results is that the 
knockdown of TMTC2 promotes greater calcium influx, possibly caused by an initial larger 
calcium release and robust activation of the stored calcium entry mechanism. The other 
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interpretation of the results, that knockdown of TMTC1 or TMTC2 reduces the capacity for 
SERCA2B to sequester cytoplasmic calcium is not supported by the comparable amplitude of the 
calcium rise induced by the agonists. The observation that no additive effect was observed with 
either co-expression or co-knockdown of both TMTC1 and TMTC2 implies that TMTC1 and 
TMTC2 do not act synergistically. It is worth noting that in both overexpression and knockdown 
studies, TMTC2 gave a stronger response then TMTC1, which may be attributed to the 
interaction between TMTC2 and calnexin. Future studies should address the role of calnexin on 
the function of TMTC2.  
The interaction between calnexin and SERCA2B can be modified by reversible post-
translational phosphorylation or palmitoylation of calnexin (Lynes et al., 2013; Roderick et al., 
2000). Phosphorylation of the C-terminal cytoplasmic tail of calnexin is believed to reduce 
sequestering by SERCA2B, whereas palmitoylation of calnexin is proposed to increase 
SERCA2B activity. Since knockdown of TMTC2 increased calcium release, it is possible that 
this is accompanied by changes in post-translational modifications of calnexin. Furthermore, the 
decreased interaction between TMTC2 and calnexin caused by inhibition of glucosidase could be 
due to changes in post-translational modifications on either SERCA2B or calnexin (Figure 2.5C). 
Collectively, these modifications allow for a dynamic control of calcium sequestering adjustable 
to the current needs of the cell. 
An RNAi based screen for proteins that effect protein trafficking found that knockdown 
of TMTC1 caused a reduction in the level of a viral glycoprotein localized to the cell surface and 
that the Golgi appeared dispersed (Simpson et al., 2012). In our study, knockdown of TMTC1 or 
TMTC2 in HeLa cells did not cause a significant defect in either ER or Golgi morphology. This 
discrepancy could be caused by differences in the HeLa strains employed (Landry et al., 2013). 
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The identification of TMTC1 and TMTC2 as ER membrane adapters and their 
interactions with SERCA2B highlights the exquisite organization and functional regulation of the 
ER and its components to carry out specific functions. The discovery of two additional regulators 
of intracellular calcium further highlights how central calcium signaling is to many aspects of cell 
biology and how carefully the signal is controlled and regulated. While both TMTC1 and TMTC2 
appeared to disrupt calcium sequestering, only TMTC2 appeared to do so in cohort with calnexin. 
The precise mechanism for how TMTC1 and TMTC2 regulate SERCA2B activity is unclear, 
future studies will be aimed to further investigate how TMTC1 and TMTC2 influence calcium 
homeostasis.  
Materials and methods 
Reagents and plasmids  
Dulbecco’s modified Eagle medium (DMEM), calcium free DMEM, fetal calf serum 
(FCS), penicillin, streptomycin, and Zysorbin were purchased from Invitrogen. 1-
deoxynojirimycin (DNJ) and Easy-Tag [
35
S]-Cys/Met were purchased from Toronto Research 
Chemicals and PerkinElmer, respectively. S-protein agarose beads and S-tag antibody were 
purchased from EMD Millipore. EndoH, PNGase F, AMV first strand synthesis kit, and all 
cloning reagents were purchased from New England Biolabs. FastStart Sybr Green qPCR mix 
was purchased from Roche, and all primers were acquired from IDT DNA. Anti-mouse-HRP 
IgG, anti-rabbit-HRP IgG, and protein A Sepharose CL-4B were purchased from GE Healthcare. 
Antibodies directed towards the following antigens were also purchased: SERCA2 (Cell 
Signaling); myc (Cell Signaling); calnexin (Enzo Life Sciences); calreticulin (Thermo scientific); 
and GM130 (BD Biosciences). TMTC1 and TMTC2 cDNA were purchased (Open Biosystems), 
and cloned into a pcDNA3.1 A-, a plasmid harboring either a C-terminal S- or myc- tag, using 
standard molecular biology techniques. TMTC1 and TMTC2 were tagged with GFP by inserting 
the GFP cDNA between the coding region and the C-terminal S-tag. These constructs were 
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termed TMTC1GFP and TMTC2GFP. The pcDNA3.1 A- S-tag backbone was modified to 
possess a N-terminal BiP signal sequence prior to the multiple cloning site and a KDEL sequence 
after the C-terminal S-tag. The TPR domains of TMTC1 and TMTC2 were cloned into this 
plasmid to create the TMTC1TPR and the TMTC2TPR constructs. shRNA plasmids were 
purchased from Qiagen. All other chemicals were obtained from Sigma-Aldrich. 
 In silico analysis of TMTC1 and TMTC2  
The primary amino acids sequence of TMTC1 and TMTC2 were analyzed by UniProtKB 
and TPRpred to identify the number and position of putative TPR domains (Karpenahalli et al., 
2007; UniProt, 2013). Hydrophobic domains were identified by the ΔG software, which predicts 
transmembrane domains (Hessa et al., 2007). Homologues of TMTC1 and TMTC2 were 
identified by Basic Local Alignment Search Tool (BLAST) searches (Altschul et al., 1990). The 
similarity and identify of TMTC1 and TMTC2 were determined using Clustal Omega software 
(Sievers et al., 2011). 
 Tissue culture 
Human embryonic kidney (HEK) 293T or COS7 cells were grown in DMEM 
supplemented with 10% fetal calf serum, 100 U/ml penicillin, and 100 mg/ml streptomycin, and 
incubated at 37 0C in 5% CO2. Cells were transfected with polyethylenimine (PEI) and the 
appropriate plasmids for 16 hr. 
 Microscopy 
Cells were fixed with 4% paraformaldehyde in phosphate buffered saline (PBS) for 10 
min at room temperature followed by permeabilization with methanol for 10 min at -20 °C. Slides 
were stained with the indicated primary antibody followed by staining with appropriate Alexa 
Fluor 488 or 594 secondary antibodies in immunostaining buffer (20 mM HEPES [pH 7.5], 150 
mM NaCl, 2 mM MgCl2, 1 mM EGTA, and 2% bovine serum albumin). Slides were rinsed and 
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mounted onto cover slips with VectaShield (Vector Laboratories). Images were obtained with a 
Flouview 1000 MPE, IX81 motorized inverted research microscope (Olympus Inc.) equipped 
with a Hamamatsu C8484-05G camera. All images were acquired with a Plan Apo N 60x 1.42NA 
lens and processed by using the FV10-ASW and the Adobe Photoshop software.  
 Radiolabeling, affinity purification and glycosylation assay 
Radiolabeling of proteins with [
35
S]-Cys/Met was performed as previously described 
(Svedine et al., 2004). Cells were lysed in MNT buffer (0.5% Triton X-100, 20 mM MES, 100 
mM NaCl, 20 mM Tris-HCl [pH 7.5]). All steps were conducted at 4 0C. The post-nuclear 
supernatant (PNS) was isolated by centrifugation followed by pre-clearing with Zysorbin for 1 hr. 
Cleared supernatant was incubated with S-protein agarose beads overnight and subsequently 
washed twice with MNT buffer. After the final MNT wash, glycosylation assays were performed 
by adding appropriate buffers and either mock, Endo H or PNGase F enzymes according to the 
manufacturer’s protocol. Finally, reducing sample buffer was added to all samples, and they were 
analyzed by SDS-PAGE. 
 Alkaline extraction 
Alkaline extraction was performed as previously described (Tamura et al., 2011). Briefly, 
radiolabeled cells were resuspended in ice-cold homogenization buffer (20 mM HEPES, pH 7.5, 
5 mM KCl, 120 mM NaCl, 1 mM EDTA, and 0.3 M sucrose) and passed through a 22-gauge 
needle 20 times. All subsequent steps were conducted at 4 
0
C. The homogenate was centrifuged 
at 1,000 g for 10 min to pellet the nuclear fraction. The remaining PNS was centrifuged at 45,000 
rpm in Beckman rotor (TLA 120.2) for 10 min to separate the cytosol (supernatant) from the 
cellular membranes (pellet). The cellular membrane fraction was resuspended in homogenization 
buffer, and a portion of the resuspended membranes was incubated with 0.1M Na2CO3 (pH 11.5) 
for 30 min on ice. The alkaline extracted portion was centrifuged at 65,000 rpm for 20 min 
through a sucrose cushion (50 mM triethanolamine, 0.3 M sucrose, pH 7.5) to separate soluble 
43 
 
proteins from membrane proteins in the supernatant and pellet, respectively. The pH was adjusted 
in the alkaline extracted sample with 1 M Tris-HCl (pH 7.5). An excess of MNT was added to all 
fractions, and immunoprecipitation or affinity precipitation was performed with protein-A 
sepharose and appropriate antisera or with S-protein agarose, respectively.  
 Trypsin protection 
Radiolabeled cells were homogenized, and the microsomes were purified as described 
above. Microsomes were resuspended in homogenization buffer, and 10 µg trypsin and/or Triton 
X-100 was added to a final concentration of 0.1%. After incubation for 15 min at 27 °C, the 
reaction was quenched with 5 µg soybean trypsin inhibitor. Samples were then resuspended in 
MNT, and affinity purification was performed as described above. 
 qRT-PCR  
HEK293T cells were treated with either 5 mM dithiothreitol, 0.5 µM thapsigargin, 5 
µg/ml tunicamycin or starved for Cys and Met for 8 hr prior to RNA isolation with RNeasy Mini 
Kit (Qiagen). One µg of purified RNA was reverse transcribed into cDNA using the AMV 
Reverse Transcriptase kit (New England Biolabs). Quantitative real time polymerase chain 
reactions (qRT-PCR) were performed in 20 µL reactions using FastStart universal SYBR Green 
master (Rox) kit (Roche Diagnostics Corp.) on a Mx3000P real-time PCR machine (Agilent 
Technologies Inc) according to manufacturer’s instructions. Changes in mRNA levels were 
calculated using the change in cycle threshold value method with β-actin as the reference gene 
(Pfaffl, 2001). Statistical analysis of the data was calculated using GraphPad Prism 4.0 (GraphPad 
Software), significance between treatment groups was determined using one-way ANOVA 
followed by Tukey multiple comparison tests.  
The following primers were used: Beta actin (5’ GCACTCTTCCAGCCTTCC 3’, 5’ 
TGTCCACGTCACACTTCATG 3’), BiP (5’ GCTGTTTCTATTGGCCTTTCTC 3’, 5’ 
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TGTCTCTTTCACCAGCATCG 3’), TMTC1 (5’ GCTGTTTCTATTGGCCTTTCTC3’, 5’ 
TGTCTCTTTCACCAGCATCG 3’), TMTC2 (5’ GATGTCTTTGTCTTTCACAGGC 3’, 5’ 
TGTTTCCCATCCAGTATAACCG 3’). 
 shRNA knockdown  
Polycistronic plasmids that express a cytoplasmic GFP and a predesigned shRNA were 
purchased from Qiagen. HEK293T cells were transfected with the shRNA for 24 hr prior to RNA 
purification and qRT-PCR as described above. To determine transfection efficiency, HEK293T 
cells were transfected for 24 hr followed by trypsinization and resuspension in DMEM. 
Resuspended cells were loaded onto a Guava Easy Flow Cytometer (Millipore). Transfected 
versus non-transfected cells were distinguished based on fluorescence from the cytoplasmic GFP. 
A total of 5,000 events were counted per measurement.  
 In gel digestion and LC-MS/MS  
Transfected cells were homogenized and microsomes were purified as described above. 
Microsomes were resuspended in mass spectrometry buffer (50 mM Hepes pH 7.4, 300 mM 
NaCl, 25 mM EDTA, 1% Triton X-100) followed by affinity purification with S-protein agarose 
beads. Beads were washed twice in MS buffer and twice with 50 mM ammonium bicarbonate 
followed by resuspension in reducing sample buffer. Samples were loaded onto a SDS-PAGE and 
allowed to run approximately 1 cm into a gel before trypsin digestion. Tryptic peptides were 
lyophilized, resuspended and loaded onto a custom column that eluted into a Proxeon Easy 
nanoLC system directly coupled to a LTQ Orbitrap Velos mass spectrometer (Thermo Scientific). 
The Orbitrap was set to achieve full scans from 350-2000 m/z with a resolution of 6000. The 
LTQ ion trap instrument performed ten scans. Data was analyzed with either Mascot Distiller 
(Matrixsciences, Ltd.) or Extract_ MSN (Thermo Scientific). The Mascot Search engine 
(Matrixsciences, Ltd.) and SwissProt database were used for protein identification. Trypsin 
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digestion and subsequent steps were performed by the Proteomics and Mass Spectrometry 
Facility, University of Massachusetts Medical School for mass spectrometric analysis. 
 Immunoblotting and affinity purification 
Transfected cells were suspended in homogenization buffer. Part of the homogenate was 
centrifuged at 45,000 rpm for 10 min to purify microsomes; the pellet was resuspended in 
reducing sample buffer and was considered the total membrane fraction. An excess of MNT 
buffer was added to an equal portion of homogenate and preclearing was performed with control 
agarose beads, followed by affinity purification with S-protein agarose beads overnight. Beads 
were washed twice in MNT buffer. Reducing sample buffer was added, and samples were loaded 
onto a SDS-PAGE. Proteins were transferred to a polyvinylidene difluoride membrane and 
immunoblotted with the appropriate antisera. Blots were developed and TIFF files were acquired 
by a G:Box (New England BioGroup), densitometric quantification of western blots were 
performed using MultiGauge software (Fuji film). The TMTC2 and calnexin interaction was 
calculated by dividing the amount of calnexin in the S-tag AP with the amount of calnexin in the 
total membranes fraction, with or without DNJ. The interaction with TMTC2 and calnexin in 
absence of DNJ was then set to 100%. Error bars represent the standard deviation for three 
independent experiments. 
 Sucrose gradient centrifugation 
Transfected cells were lysed in MNT, and the post-nuclear supernatant was layered on 
top of a continuous 10-40% sucrose gradient with a 60% cushion in MNT buffer. The gradients 
were centrifuged for 16 hr at 4 °C with a Beckman SW41 at 145,000g. Standards used to 
determine sedimentation velocities were bovine serum albumin (4.6S, 66 kD), beta-amylase 
(8.9S, 200 kD) and bovine thyroglobulin (19S, 669 kD). After centrifugation, 9% of total gradient 
volume was collected per fraction, and proteins were isolated with trichloroacetic acid 
precipitation. Samples were resuspended in reducing sample buffer and analyzed by 
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immunoblotting with the appropriate antisera. After the last fraction was collected, the pellet was 
processed by adding sample buffer directly to the ultracentrifugation tube.  
 Live cell calcium measurement 
HEK293T cells were plated on a glass bottom 3.5 cm dish and transfected the following 
day. Cells were loaded with 2.5 μM Fura2-AM (Molecular Probes, Eugene, OR, USA) and 2.5 
μM Pluronic F­127 for 45 min 16 hr post-transfection. Plates were washed with fresh media and 
incubated for 45 min to allow hydrolysis of the Fura2-AM ester. Plates were then rinsed with 
fresh media and placed on an inverted microscope with a 20× objective (Nikon Corp., Tokyo, 
Japan). Fluorescence was measured every 20 sec, and the excitation wavelength was switched 
between 340 and 380 nm by a filter wheel. After stable baseline fluorescence had been 
established, carbachol and ATP (final concentration 100 µM for each) were added to media to 
release intracellular calcium. Light emitted by Fura2 was collected by a cool SNAP ES digital 
camera, and all obtained data was processed using SimplePCI software. Statistical analysis and 
area under curve calculations were completed using GraphPad Prism 4.0 software. The area under 
the curve was calculated by subtracting the baseline for each of the cells prior to the addition of 
carbachol. Once individual areas under the curve were obtained, the measurements were averaged 
for all cells in that treatment. The average calculated for the mock was set to 1.00 and the values 
of the treated cells were calculated relative to this number. Statistical significance was calculated 
using an unpaired t test. Cells analyzed in all Fura2 experiments were from at least five different 
plates collected on three separate days. Experiments with ionomycin were carried out in the same 
manner with the exception of calcium free media being used during imaging. 
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# of unique peptides 
Name Mock TMTC1 TMTC2 
SERCA2 9 37 27 
Glucosidase II subunit alpha 11 23 23 
Calnexin 8 21 21 
BiP 5 21 17 
Long-chain-fatty-acid--CoA ligase 3 4 21 14 
GRP-94 10 19 17 
GRP170 3 14 11 
Ribophorin-1 6 13 11 
Neuropathy target esterase 0 11 6 
IP3 receptor type 3 0 11 3 
Ribophorin-2 0 10 10 
Kinectin 4 10 8 
IP3 receptor type 2 0 10 1 
HMG-CoA reductase 0 9 4 
PLOD1 0 8 10 
SR-alpha 1 8 2 
Nodal modulator 2 1 7 11 
P16435 3 7 4 
Protein disulfide-isomerase 0 7 1 
Aspartyl/asparaginyl beta-hydroxylase 0 6 7 
STT3-A 0 6 6 
Lanosterol synthase 0 6 3 
Sphingomyelin phosphodiesterase 4 0 5 4 
Erlin-2 1 5 3 
 
 
Table 2.1 Putative binding partners of TMTC1 and TMTC2 
 
Putative binding partners of TMTC1 and TMTC2 as determined by LC-MS/MS. Proteins are 
ranked by number of unique peptides identified that originates from the corresponding proteins 
compared to mock transfected cells.  
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Figure 2.1 Organization and transcription of TMTC1 and TMTC2 isoforms. 
 
(A) The organization of TMTC1 (TMTC1 isoform 2) and TMTC2 with signal sequences (black 
boxes), hydrophobic domains (green boxes) and TPR domains (red boxes) as designated. 
Endogenous and introduced N-linked glycosylation sites are indicated by black branched 
structures and asterisks, respectively. (B) There are two possible isoforms of TMTC1 designated 
as TMTC1.1 (TMTC1 isoform 1 (NCB Accession # NP_001180380.1 
(http://www.ncbi.nlm.nih.gov/protein/NP_001180380.1)) and TMTC1.2 (TMTC1 isoform 2 
(NCB Accession # NP_787057.2 (http://www.ncbi.nlm.nih.gov/protein/NP_787057.2))). The 
open reading frame is indicated in black while the different 5’-untranslocated regions are 
designated by brown (TMTC1.1) and green (TMTC1.2) boxes. Different 5' primers (P1-P4) were 
designed to amplify specific isoforms using the same 3' primer (P5). (C) RNA was reverse 
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transcribed to cDNA followed by PCR with TMTC1 isoform specific primers. P1 and P2 are 
specific for TMTC1.1 (lanes 1 and 2) while P4 is specific for TMTC1.2 (lane 4). P3 is directed 
towards both isoforms (lane 3). PCR products were resolved by agarose gel electrophoresis with 
the nucleotide base pair makers (kbp) indicated to the right. 
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Figure 2.2 TMTC1 and TMTC2 are ER localized. 
 
(A) Cellular localization of TMTC1 and TMTC2 was investigated by confocal microscopy. 
COS7 cells were transfected with TMTC1 or TMTC2 cDNA. Fixed cells were stained with myc, 
ERp57 (ER) or GM130 (Golgi) antisera. Nuclei were visualized by DAPI staining (blue). Scale 
bars correspond to10 µm. (B) HEK293T cells were transfected with S-tagged TMTC1 or TMTC2 
as indicated and radiolabeled for 1 hr with [
35
S]-Cys/Met. Cells and media were collected. 
TMTC1 and TMTC2 from the media and lysed cells were affinity purified using S-protein 
agarose. Samples were then subjected to a glycosylation assay with either Endo H (lanes 2, 5, 8 
and 11) or PNGase F (lanes 3, 6, 9 and 12) digestion as indicated. Reducing sample buffer was 
added, and the samples were analyzed by 7.5% SDS-PAGE. (C) Two N-linked glycosylation sites 
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were introduced into TMTC1 (TMTC1
N626, 633
) and TMTC2 (TMTC2
N602, 818
). Added glycan 
positions are indicated by the asterisks in Figure 1A. Samples were treated and digested as in B. 
Molecular weight markers are designated in kD to the right for all SDS-PAGE panels. 
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Figure 2.3 TMTC1 and TMTC2 are upregulated by oxidative stress. 
 
HEK293T cells were treated with regular growth media or media containing 5 mM DTT, 1 μM 
thapsigargin, 5 μg/mL tunicamycin or media lacking Cys and Met (-Cys/Met) for 8 hr prior to 
RNA purification. RNA was reverse transcribed to cDNA followed by qRT-PCR with 
appropriate primers, and changes in gene expression were calculated using beta actin as a 
reference. Statistical significance between treatment groups was determined using one-way 
ANOVA followed by Tukey multiple comparison tests, ** and *** indicates a P-value of less 
than 0.01 and 0.001, respectively. Error bars represent standard deviation from at least three 
independent experiments. 
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Figure 2.4 TMTC1 and TMTC2 are ER membrane proteins with their TPR domains facing the 
ER lumen. 
 
(A) HEK293T cells expressing S-tagged TMTC1 or TMTC2 were radiolabeled for 1 hr followed 
by homogenization, fractionation and alkaline extraction. The fractions collected were whole cell 
lysate (WCL), nucleus (N), cytosol (C), total membrane (TM), as well as supernatant (S) and 
pellet (P) fractions upon alkaline extraction of the TM. Samples were resolved by reducing 7.5% 
SDS-PAGE. (B) TMTC1-S-tag or TMTC2-S-tag was expressed in HEK293T cells. After 
radiolabeling for 1 h, cells were homogenized, and microsomes were purified by 
ultracentrifugation then resuspended in homogenization buffer. Aliquots of the ER microsomes 
were incubated for 10 min at 27 ˚C without (lanes 1, 5 and 9) or with 0.1% Triton X-100 and 10 
µg trypsin (lanes 4, 8 and 12) as indicated. TMTC1 or TMTC2 were affinity purified with S-
protein agarose beads. Samples were resolved on a reducing 9% SDS-PAGE.  
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Figure 2.5 TMTC1 and TMTC2 interact with SERCA2B. 
 
(A) HEK293T cells were transfected as indicated and homogenized prior to purification of 
microsomes by ultracentrifugation. TMTC1 or TMTC2 was isolated with its associated factors 
from microsomes in MS buffer using S-protein agarose affinity precipitation. A portion of the 
samples was loaded onto a SDS-PAGE and silver stained to verify enrichment of putative binding 
partners. A separate portion of the affinity-purified sample was run on a short SDS-PAGE before 
excision of the sample and in gel trypsin digestion. Tryptic peptides were injected into a LC-
MS/MS instrument followed by peptide identification. (B) HEK293T cells expressing TMTC1 or 
TMTC2 were harvested in homogenization buffer. A portion of the cell homogenate was 
subjected to ultracentrifugation and resuspended in reducing sample buffer. This was considered 
the total membrane fraction. An excess of MNT was added to an equal amount of cell 
homogenate and subjected to S-protein agarose affinity precipitation. Proteins were detected by 
immunoblotting with appropriate antisera directed against the S-tag epitope, SERCA2B, calnexin 
(CNX), BiP, glucosidase II subunit alpha (Gls II α), calreticulin (CRT) and ERp57. (C) 
HEK293T cells were treated with N-butyl deoxynojirimycin (DNJ) for 4 hr prior to 
homogenization where indicated, and samples were processed as in B. Quantification of the 
TMTC2 and calnexin interaction was calculated as described above, error bars represent standard 
deviation of three independent experiments. Statistical significance between treatment groups was 
determined by an unpaired t test, measurements designated (*) have a P value of 0.0233. (D) 
HEK293T cells were transfected as indicated above. Cells were lysed in MNT, and samples were 
layered on top of a continuous 10-40 % sucrose gradient in MNT buffer prior to 
ultracentrifugation. Fractions were collected from the top of the gradient, and proteins were 
precipitated with trichloroacetic acid. Immunoblotting was then performed with appropriate 
antisera as described above. Sizing of detected complexes was estimated by comparison to the 
following standards designated at the bottom of the immunoblots; bovine serum albumin (4.6S, 
66 kDa); beta-amylase (8.9S, 200 kDa); and bovine thyroglobulin (19S, 669 kDa). 
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Figure 2.6 The TPR domains of TMTC1 and TMTC2 are sufficient to interact with SERCA2B. 
 
(A) COS7 cells were transfected with TMTC1
TPR
 and TMTC2
TPR
, and
 
cells were treated and 
stained as described in Figure 1B. (B) HEK293T cells were transfected with either TMTC1
TPR
 or 
TMTC2
TPR
, harvested and homogenized. Total membrane fractionation and affinity precipitation 
were performed as described in Figure 5B. Proteins were detected with appropriate antisera 
against the S-tag, SERCA2B, calnexin (CNX), BiP, glucosidase II subunit alpha (Gls II α), 
calreticulin (CRT).  
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Figure 2.7 Overexpression of TMTC1 and TMTC2 decreased stimulated calcium release.  
 
(A) COS7 cells were transfected with TMTC1
GFP
 or TMTC2
GFP
, treated, stained and analyzed as 
in Figure 2.1B. (B) HEK293T cells transfected with TMTC1
GFP
, TMTC2
GFP 
or cotransfected with 
both were incubated with Fura2-AM followed by incubations in fresh media. Changes in 
cytoplasmic calcium were determined by measuring the ratio of fluorescence emission after 
excitation at 340 and 380 nm. Basal calcium levels were recorded to create a stable baseline 
before calcium release was stimulated with the addition of 100 µM ATP and 100 µM carbachol to 
the media (see bar). A total of 386, 91, 103 and 106 cells were measured for non-transfected 
control, TMTC1
GFP
, TMTC2
GFP 
and cotransfection of TMTC1
GFP
 with TMTC2
GFP
, respectively. 
Error bars represent standard error of the mean. The area under the curve is relative to the total 
amount of calcium released from the ER upon stimulation (bar graph). Statistical significance 
between non-transfected cells and either TMTC1
GFP
, TMTC2
GFP
, or the
 
TMTC1
GFP
 TMTC2
GFP 
cotransfection was calculated by using an unpaired t-test. Measurements designated (***) had a P 
value of <0.0001. Error bars represent standard error of the mean. (C) HEK293 cells were 
transfected with TMTC1
GFP
, and live cell calcium measurements were performed as in B. Basal 
calcium levels were recorded before 2 μM ionomycin (see bar) was added to media to release 
intracellular calcium. All recordings were performed in calcium free media to prevent 
interference from extracellular calcium. A total of 130 and 78 cells were analyzed for non-
transfected control and TMTC1
GFP
, respectively. The area under the curve is relative to the total 
amount of calcium released from the ER upon stimulation (bar graph). Statistical significance 
between non-transfected cells and TMTC1
GFP
 was calculated using an unpaired t-test, 
measurements designated (**) have a P value of 0.0022. Error bars represent standard error of the 
mean. (D) HEK293 cells were transfected with TMTC2
GFP
, and live cell calcium measurements 
were performed as in C. A total of 140 and 100 cells were analyzed for non-transfected control 
and TMTC2
GFP
, respectively. Statistical significance between non-transfected cells and 
TMTC2
GFP
 was calculated by using an unpaired t-test. Measurements designated (**) have a P 
value of > 0.0001. Error bars represent standard error of the mean. 
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Figure 2.8 Knockdown of TMTC1 and TMTC2 increased stimulated calcium release. 
 
(A) HEK293T cells were transfected with polycistronic plasmids that expressed shRNA (directed 
towards TMTC1 or TMTC2 transcripts) and cytoplasmic GFP. RNA was purified from 
HEK293T cells, and the RNA was reverse transcribed to cDNA followed by qRT-PCR. Changes 
in gene expression were measured using beta actin as a reference gene. Fold reduction in TMTC1 
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or TMTC2 mRNA abundance was compared to mock transfected cells. Four different shRNA and 
a scrambled negative control were tested for knockdown of TMCT1 and TMTC2. Error bars 
indicated standard deviation from three independent experiments. HEK293T cells transfected 
with the different shRNA constructs and GFP were also analyzed and scored as non-transfected 
or transfected based on GFP fluorescence using flow cytometry. A total of 5,000 cells were 
counted per experiment and standard deviations were calculated from at least two separate 
experiments. (B) HEK293T cells were transfected with either TMTC1 shRNA1, TMTC2 
shRNA3 or cotransfection with TMTC1 shRNA1 and TMTC2 shRNA3. Live cell calcium 
measurements were performed as in Figure 7B. Once a stable baseline was obtained, 100 µM 
ATP and 100 µM carbachol was added to the media (see bar). A total of 297, 137, 115 and 208 
cells were measured for non-transfected control, TMTC1 shRNA1, TMTC2 shRNA3 and the 
cotransfection of TMTC1 and TMTC2 shRNAs, respectively. Error bars represent standard error 
of the mean. The area under the curve is relative to the total amount of calcium released from the 
ER upon stimulation. Statistical significance between non-transfected cells and either TMTC1 
shRNA1 or TMTC2 shRNA3 was calculated by using an unpaired t test. Measurements 
designated (***) have a P value of <0.0001. Error bars represent standard error of the mean. 
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CHAPTER III 
 
TMTC3, TMTC4, TTC13 AND TTC17 ARE ER TPR CONTAINING PROTEINS 
 
Abstract 
Although the endoplasmic reticulum (ER) consists of a contiguous membrane and lumen, 
evidence of compartmentalization into sub-domains within the organelle has emerged. The ER is 
believed to be dependent on adapter proteins, which can aid in ER compartmentalization by 
nucleating the formation of protein complexes. Tetratricopeptide repeats (TPR) are adapter motifs 
that are known to organize proteins into complexes in a wide range of cellular processes. While a 
large number of TPR containing proteins have been predicted to exist in the human genome, only 
a few have been localized to the ER. To this end, a bioinformatics screen was conducted to 
identify novel ER TPR containing proteins as described in Chapter I. Subsequent biochemical and 
cell biological assays identified TTC13 and TTC17 as ER luminal proteins, whereas TMTC3 and 
TMTC4 were found to be ER membrane proteins with their TPR domains facing the ER lumen. 
A shotgun proteomics approach was employed to identify novel binding partners of TTC13, 
TTC17, TMTC3 and TMTC4. An interaction with TMTC4 and the lectin chaperone calnexin was 
verified by co-affinity precipitation, though the significance of this interaction is currently 
unknown. Collectively, this study provided a useful method for identifying novel ER TPR 
proteins and the approach could be employed to study another protein fold in the ER. 
Introduction 
The endoplasmic reticulum (ER) extends throughout the cell body and is responsible for 
a plethora of functions in the ER such as protein folding, trafficking, degradation, lipid synthesis, 
calcium homeostasis and xenobiotic degradation (Lynes and Simmen, 2011). The ER can be 
classified as rough ER sheets where ribosomes dock on the ER membrane or smooth ER sheets 
for regions of the ER membrane lacking ribosomes (Levine and Rabouille, 2005; Voeltz et al., 
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2002). Furthermore, the ER can also be shaped into tubules that extend outward and make 
contacts with other organelles. The shape, size and intracellular distribution of the ER is under 
constant modification by external cues such as contacts with other organelles and the 
cytoskeleton. Despite being a continuous organelle, the ER appears to be organized into sub-
domains (Lynes and Simmen, 2011). It has been postulated that this organization is maintained by 
adapter proteins that organize multi-protein complexes to assist in the various functions of the ER 
in the different sub-domains. 
Tetratricopeptide repeats (TPR) are a common motif found in various adapter proteins 
(D'Andrea and Regan, 2003; Zeytuni and Zarivach, 2012). They are universally found in all 
organisms and multiple and diverse pathways. These motifs consist of 34 amino acids that fold 
into two anti-parallel alpha helices. While there is no consensus sequence of the motifs, there 
tends to be a preference for certain amino acids at defined positions. A search of databases 
predicts that the human genome encodes for ~170 proteins with TPR motifs (Letunic et al., 2012; 
UniProt, 2013). Out of these, only ERdj6 and SEL1L have previously been localized to the ER. 
Since one third of the human genome is predicted to be targeted to the secretory pathway, we 
hypothesized that there might be additional currently ER resident TPR proteins that contribute to 
ER organization. 
To further our understanding of TPR proteins in the ER and their role in organization and 
compartmentalization of the ER, a screen was conducted as described in Chapter II. Briefly, an in 
silico library was acquired from L Regan's lab (Yale University) (Magliery and Regan, 2005), 
and the library was expanded by utilizing BLAST database (Altschul et al., 1990). This list 
generated nine hits, and of these, TMTC1 and TMTC2 were extensively characterized in Chapter 
II. However, this bioinformatics screen also resulted in the identification of TMTC3, TMTC4, 
TTC9B, TTC13, TTC17, TTC35 and NASP. This chapter will focus on the characterization of 
these additional seven proteins. By employing various biochemical and cell biological assays, we 
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found that TMTC3, TMTC4, TTC13 and TTC17 were targeted to the secretory pathway. While 
TMTC3 and TMTC4 were found to be integral membrane proteins with their TPR domains 
facing the ER lumen, TTC13 and TTC17 were found to be ER luminal proteins. Shotgun 
proteomics implied that TMTC4 interacts with fatty acid synthase, calnexin and p97 (a 
cytoplasmic AAA ATPase). Co-affinity precipitation studies verified the TMTC4 and calnexin 
interaction but the remaining interaction remain to be validated. 
Results 
The bioinformatics screen conducted in Chapter II resulted in nine hits (Figure 1.1), 
while TMTC1 and TMTC2 were characterized in the previous chapter, TMTC3, TMTC4, 
TTC9B, TTC13, TTC17, TTC35 and Nuclear autoantigenic sperm protein (NASP) were also 
predicted to be ER targeted (Figure 3.1). NASP was previously shown to be important for histone 
assembly in the nucleus, and TTC35 had been found to be a cytoplasmic protein localized to the 
cytoplasmic face of the ER membrane (Batova and O'Rand, 1996; Christianson et al., 2012). 
Analysis by the ΔG algorithm predicted that TMTC3 and TMTC4 were membrane inserted, 
whereas TTC9B, TTC13, TTC17, TTC35 and NASP appear to be soluble proteins (Hessa et al., 
2011). To test these predictions and to query the cellular localization of TMTC3, TMTC4, 
TTC9B, TTC13, TTC17, TTC35 and NASP, RNA was harvested from HEK293T cells and 
converted into cDNA. This library of cDNA was then used as a PCR template to amplify specific 
open reading frames, which were subcloned into a mammalian expression vector with a C-
terminal S-tag.  
The cellular localization of TMTC3, TMTC4, TTC9B, TTC13, TTC17, TTC35 and 
NASP was investigated with confocal microscopy by transfecting Cos7 cells with corresponding 
a C-terminal S-tag constructs. Cells were co-stained with either an ER (ERp57) or a Golgi 
(GM130) marker, and the nucleus was visualized by DAPI staining. TMTC3, TMTC4, TTC13 
and TTC17 all showed a clear colocalization with the ER marker but not with the Golgi marker 
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(Figure 3.2). Conversely, TTC9B and TTC35 appeared cytoplasmic and NASP was primarily 
found in the nucleolus. The subcellular localization for NASP and TTC35 agrees with previously 
published data (Christianson et al., 2012; Richardson et al., 2000). TMTC3, TMTC4, TTC13 and 
TTC17 were identified as ER localized TPR containing proteins by confocol microscopy.  
TMTC3 and TTC17 are upregulated by DTT 
Proteins that reside in the secretory pathway are frequently transcriptionally induced by 
stress as their functions can help to alleviate the stress (Walter and Ron, 2011). To this end, we 
measured the changes in transcription during oxidative stress (dithiothreitol, DTT), SERCA2B 
inhibition (thapsigargin), inhibition of N-linked glycan synthesis (tunicamycin) or starvation of 
cysteine and methionine for 8 hr. TMTC3, TMTC4, TTC9B, TTC13 and TTC17 had a 2.19, 1.64, 
2.77, 2.09 and a 3.10- fold transcriptional activation upon DTT treatment, respectively (Figure 
3.3B). Additionally, administration of thapsigargin caused a 2.14-fold increase in TTC13 
transcription, whereas tunicamycin caused a 1.99 fold transcriptional increase of TTC17. 
Addition of DTT, thapsigargin or tunicamycin caused a 26.1, 12.3 and 11.9 fold induction of BiP 
transcript levels, which agrees with published data (Hetz, 2012). Additionally, a 0.53 and 0.59 
fold reduction of NASP transcript levels were observed upon tunicamycin treatment or starvation 
of cysteine and methionine. For most genes tested, DTT caused the strongest response in 
transcription levels, which could imply that these genes are specifically upregulated by oxidative 
stress. Alternatively, the upregulation of these proteins by thapsigargin or tunicamycin could 
occur on a different time frame then induction by DTT. The observation that TTC9B transcription 
is upregulated by oxidative stress is interesting since this protein is not targeted to the secretory 
pathway, thus TTC9B might be important for ER stress signaling in the cytoplasm.  
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TMTC3, TMTC4 and TTC17 have high mannose N-lined glycans, indicative of ER resident 
proteins 
N-linked glycans are large hydrophilic sugar structures that are added co- or post- 
translationally to most secretory proteins upon ER targeting (Hebert et al., 2005). N-linked 
glycans are added to proteins with the consensus sequence N-X-S/T, where X is any amino acid 
except proline. However, recent studies have highlighted that there is a propensity for certain 
amino acids before and after the consensus sequence, which can affect how well a glycosylation 
site is recognized (Zielinska et al., 2012; Zielinska et al., 2010). To corroborate the ER 
localization implied by the confocal microscopy data, a glycosylation assay was employed. This 
assay depends on the observation that addition of a N-linked glycan to a protein increases its 
molecular weight by approximately 2.5 kD, which can be visualized by a slower migration by 
SDS-PAGE. Furthermore, these N-linked glycans can be removed by either Endoglycosidase H 
(Endo H) and/or Peptide N-Glycosidase F (PNGase F), enzymes that trim carbohydrates from 
polypeptides. Endo H can only trim the high mannose glycans encountered in the ER whereas 
PNGase F can also trim the complex glycans acquired in the Golgi. A gel shift upon PNGase F 
treatment implies that a protein was N-linked glycosylated, and a gel shift by Endo H treatment 
implies that the protein had high mannose glycan indicative of ER residency.  
HEK293T cells were transfected with TMTC3, TMTC4, TTC13 or TTC17, and proteins 
were radiolabeled for 1 hr with [
35
S]-Cys/Met followed by cell lysis and affinity purification with 
S-protein agarose beads. While TMTC3, TMTC4 and TTC17 appeared to be glycosylated, 
TTC13 did not (Figure 3.4). TMTC3 has five consensus sites for N-linked glycans, though not all 
appeared to be recognized as judged by the relatively small shift on the glycosylation assay. The 
first two glycosylation sites are positioned in the hydrophobic N-terminus of TMTC3 and might 
be either too close to the ER membrane to be recognized by oligosaccharyl transferase (OST). 
Alternatively, the glycosylation sequences could face the cytoplasm (Nilsson and von Heijne, 
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1993). Furthermore, of the three glycosylation sequences in the TPR domains, only the third 
glycan was predicted to be recognized by the NetNGly algorithm 
(http://www.cbs.dtu.dk/services/NetNGlyc/), which predicts likelihood of a consensus site being 
modified. TMTC4, compared to TMTC3, gave a larger shift on a SDS-PAGE and was likely to 
posses multiple glycans, although only the first glycan was predicted to be recognized by the 
NetNGly algorithm. The relatively large shift for TTC17 implied that many of the twelve 
potential glycosylation sites were modified. Interestingly, NetNGly predicted that only seven 
would be efficiently recognized. The glycans encountered on TMTC3, TMTC4 and TTC17 were 
all EndoH sensitive, which suggested that these proteins are ER resident proteins. TTC13 has 
only a single potential glycosylation site, which did not appear to be recognized. While the 
NetNGly algorithm predicted that TTC13 is glycosolated, the size of TTC13 could make it 
difficult to detect a 2.5 kD shift in mobility on a SDS-PAGE.  
To test if any of the proteins were secreted, the media fraction was collected after 1 hr of 
radiolabeling with [
35
S]-Cys/Met, followed by S-protein agarose affinity purification and the 
glycosylation assay. Neither TMTC3, TMTC4, TTC13 nor TTC17 were secreted into the media, 
which is consistent with an ER localization (Figure 3.4A). Additionally, the glycosylation data for 
TMTC3, TMTC4 and TTC17 agrees with the microscopy data, further indicating that these 
proteins are ER resident proteins. While no glycosylation was observed for TTC13, the 
observation that no protein was detected in the media and the microscopy supports ER residency. 
TMTC3 and TMTC4 are ER membrane proteins, whereas TTC13 and TTC17 ER luminal 
Analysis of the TMTC3, TMTC4, TTC13 and TTC17 protein sequences with ΔG 
prediction algorithm suggested that TMTC3 and TMTC4 contained eight and eleven hydrophobic 
domains, respectively. In contrast, TTC13 and TTC17 were not predicted to have hydrophobic 
domains (Figure 3.1). Since these hydrophobic domains could serve as transmembrane domains, 
an alkaline extraction assay was employed to determine if TMTC3, TMTC4, TTC9B, TTC13, 
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TTC17 and/or NASP were integral membrane proteins. HEK293T cells were transfected with a 
C-terminally S-tagged TMTC3, TMTC4, TTC9B TTC13, TTC17 and NASP and radiolabeled for 
1 hr with [
35
S]-Cys/Met followed by lysis in an isotonic buffer and separation using a series of 
centrifugation steps. 
Both TMTC3 and TMTC4 were found in the nuclear, total membrane and the pellet 
fractions, which is the same distribution as encountered for calnexin, an ER membrane anchored 
lectin chaperone. The occurrence of TMTC3 and TMTC4 in the nucleolus is likely due to the fact 
that the ER membrane is continuous with the nuclear envelope. TTC13 and TTC17 were 
encountered in the nuclear, total membranes and primarily in the soluble fraction with some 
protein in the pellet fraction. This enrichment of TTC13 and TTC17 in the soluble fraction 
implies that these proteins are luminal proteins, as observed for calreticulin, the soluble paralogue 
of calnexin. The presence of TTC13, TTC17 and calreticulin in the pellet fraction is likely an 
artifact of the alkaline extraction. In this protocol, proteins are incubated with 0.1 M sodium 
carbonate (pH 11.5) for 30 min on ice. During this treatment, a portion of the proteins might 
aggregate due to the harsh buffer conditions, and these aggregated proteins would then be 
pelleted along side membrane proteins during the last centrifugation step. In accordance with the 
microscopy data, TTC9B localized primarily to the nuclear and the cytoplasm fractions whereas 
NASP localized primarily to the cytosolic and nuclear fraction. Collectively these data indicate 
that TMTC3 and TMTC4 are integral membrane ER proteins, whereas TTC13 and TTC17 are 
soluble ER proteins.  
The TPR domains of TMTC3, TMTC4, TTC13 and TTC17 are in the ER lumen 
To further support the ER localization of TTC13 and TTC17 and to address the topology 
of the TPR domains of TMTC3 and TMTC4, a trypsin protection assay was employed. HEK293T 
cells were transfected with TMTC3, TMTC4, TTC13 or TTC17 harboring a C-terminal S-tag and 
radiolabeled for 1 hr with [
35
S]-Cys/Met. Cells were lysed in an isotonic buffer and microsomes 
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were purified by ultracentrifugation followed by re-suspension in homogenization buffer and 
incubation with trypsin and Triton X-100 as indicated. After trypsin digestion, trypsin was 
inhibited by an excess of soybean trypsin inhibitor, and affinity purification was performed using 
the C-terminal S-tag. If the S-tagged, and TPR rich, C-terminus was localized to the ER lumen, it 
would be protected from trypsin. Conversely, if the C-terminal S-tag was facing the cytoplasm, it 
would be readily available to trypsin. After trypsin inhibition, affinity purification using S-
agarose beads allowed for the isolation of proteins containing a protected C-terminus.  
A smaller, protected fragment of TMTC3 was observed on a SDS-PAGE after the trypsin 
assay. However only a portion of TMTC3 was digested by trypsin, implying that the TPR 
domains of TMTC3 are facing the ER lumen and that the cytoplasmic portion of TMTC3 is 
partially sensitive to trypsin digestion (Figure 3.5). TMTC4 remained completely protected upon 
trypsin treatment, implying that the TPR domains are facing the ER lumen. Both TTC13 and 
TTC17 were completely protected from trypsin digestion, suggesting that they are soluble 
proteins located to the ER lumen. Collectively, these data imply that the TPR domains of 
TMTC3, TMTC4, TTC13 and TTC17 are all facing the ER lumen.  
LC-MS MS to identify binding partners of TMTC1 and TMTC2 
Since TMTC3, TMTC4, TTC13 and TTC17 all are ER proteins with their TPR domains 
facing the ER lumen, the next step was to identify potential binding partners of these putative ER 
adapters. HEK293T cells were transfected with TMTC3, TMTC4, TTC13 or TTC17 harboring a 
C-terminal S-tag, cells were lysed in an isotonic buffer, and ER microsomes were purified by 
ultracentrifugation. The microsomes were then resuspended in affinity purification buffer, and 
affinity purification was performed with S-protein agarose beads. A portion of the affinity-
purified protein was then run on a SDS-PAGE followed by silver staining to verify enrichment of 
putative binding partners compared to mock transfected cells (Figure 3.6A).  
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While TTC13 and TTC17 expression was high and the proteins were clearly visible on a 
silver stained SDS-PAGE, no clear enrichment of binding partners was observed when the 
affinity purification was performed in 1% Triton X-100, a relatively harsh detergent. The 
experiment was repeated, but the AP was performed in 1% CHAPS, despite CHAPS being a 
milder detergent, no clear enrichment of putative binding partners were observed upon silver 
staining of a SDS-PAGE . To circumvent this problem, we plan to repeat the AP with either a 
gentler detergent such as digitonin or a chemical crosslinker to covalently trap the complex. 
Dithiobis[succinimidyl propionate] (DPS) is a lysine specific crosslinker with a 12Å length, 
which has the advantage of having an internal disulfide that can reduced by DTT. Thus the 
crosslinker can be released on a reducing SDS-PAGE and enrichment of putative binding partners 
can be visualized by silver staining. 
TMTC3 had a relatively low expression in the large scale AP, and only a weak 
enrichment was observed in Triton X-100 lysis (Figure 3.6). Thus the TMTC3 AP might need to 
be repeated with either a gentler detergent or a covalent crosslinker. The identification of putative 
binding partners of TMTC3, TTC13 and TTC17 is an active area of research in our laboratory. 
Conversely, expression and purification of TMTC4 in a 1% Triton X-100 buffer resulted in 
enrichment of a number of bands on a silver stained gel that could represent putative binding 
partners of TMTC4. To identify the proteins, a portion of the large AP was loaded onto a SDS-
PAGE and the dye front was allowed to run ~ 1 cm into the resolving gel. The gel segment above 
the dye front was then excised and processed for in gel trypsin digestion, followed by analysis by 
liquid chromatography–mass spectrometry/mass spectrometry (LC-MC/MS) to identify the 
tryptic peptides. This LC-MS/MS indentified a large number of putative binding partners of 
TMTC4 (Table 3.1). Potential binding partners were scored based on number of unique peptides 
that were identified from the corresponding protein. The top hits included BiP (the ER Hsp70), 
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p97 (a cytoplasmic AAA ATPase associated with diverse cellular activities, also called VCP), 
calnexin (a membrane bound lectin chaperone) and fatty acid synthase.  
TMTC4 interacts with calnexin 
To verify the binding partners of TMTC4 as implied by the LC-MS/MS, HEK293T cells 
were transfected with TMTC4 harboring a C-terminal S-tag and lysed in an isotonic buffer. A 
portion of the lysate was subjected to affinity purification with S-tag agarose beads while another 
fraction was subjected to ultracentrifugation to obtain the total membranes fraction. 
Immunoblotting against the S-tag or endogenous putative binding partners indicated that TMTC4 
interacted with calnexin but not with BiP or calreticulin (Figure 3.6). Since TMTC4 has multiple 
N-linked glycans, the interaction between TMTC4 and calnexin could be because calnexin is a 
lectin chaperone that is required for proper folding of TMTC4. Alternatively, TMTC4 could form 
a complex with protein(s) that have N-linked glycans, and the TMTC4 calnexin binding could be 
mediated through a ternary complex. No interaction between TMTC4 and BiP was observed, 
likely reflecting that BiP has a propensity to nonspecifically bind agarose and sepharose beads 
and frequently appears as a false positive in LC-MS/MS analysis of ER proteins. We are actively 
pursuing the validity of the interactions between p97, clathrin heavy chain 1 and fatty acid 
synthase with TMTC4.  
Discussion 
The ER sheets and tubules form a continuous network that extends throughout the cell 
(Voeltz et al., 2002). Despite the continuous nature of the ER, a higher level of organization and 
compartmentalization into sub-domains has been observed (Lynes and Simmen, 2011). It has 
been proposed that this organization is in part created by adapter proteins that nucleate multi 
protein complexes. This study explored the possibility that there might be additional adapter 
proteins in the ER, some of which rely upon TPR domains. TMTC3, TMTC4, TTC13 and TTC17 
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were localized to the ER as demonstrated by microscopy, cell fractionation, and glycosylation 
assays. 
TMTC3, TMTC4, TTC9B, TTC13 and TTC17 were transcriptionally upregulated by 
oxidative stress (Figure 3.3A). Additionally, TTC13 and TTC17 were transcriptionally 
upregulated by inhibition of SERCA2B or of glycan synthesis, respectively. While the statistical 
analysis implies that the observed transcriptional induction was statistically significant, the 
actually fold induction was relatively low. This could indicate that TMTC3, TMTC4, TTC9B, 
TTC13 and TTC17 only play a minor or secondary role in restoring ER homeostasis after stress. 
Additionally, during the course of this study a manuscript was published that implied that 
silencing of TMTC3 sensitized HeLa cells to ER stress, however TMTC3 was not upregulated by 
ER stress in our study (Racape et al., 2011). The transcriptional upregulation of TTC9B is 
interesting since this suggests that TTC9B somehow is linked to the ER stress signaling in the 
cytoplasm. Why oxidative ER stress commonly resulted in a larger response then other treatment 
is not clear. It could suggest that these proteins are sensitive to oxidative damage and their 
misfolding causes transcriptional upregulation as a compensatory mechanism. Alternatively, the 
different stress conditions tested could be active on different time scales and the 8 hr treatment 
used in this study failed to account for this. However, this is unlikely since a significant induction 
of BiP was observed in DTT, thapsigargin and tunicamycin treatment, implying a robust 
activation of the unfolded protein response.  
The number of sequential TPR motifs in a cluster of TPR motifs can give clues as to the 
nature of the ligand. Smaller clusters tend to interact with more specific ligands whereas larger 
clusters tend to be more promiscuous in their binding partner (D'Andrea and Regan, 2003; 
Zeytuni and Zarivach, 2012). In the case of Hop, Pex5 and TOM70, clusters of 3 TPR motifs 
recognize a peptide of three or four amino acids located at the extreme C-termini of their 
substrate (Chen and Smith, 1998a; Gatto et al., 2000; Young et al., 2003). Analogous to this, 
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several ER proteins, including BiP and GRP94, possess C-terminal KDEL sequences, which are 
utilized for ER retention. Since TTC17 has two separate clusters of three TPR domains, it is 
conceivable that these domains are designed to interact with a well-defined ER resident ligand, 
such as the KDEL. To address this, the different clusters of TPR domains as well as the wild type 
TTC17 could be expressed in HEK293T cells and binding to BiP and GRP94 could be addressed 
by co-affinity purification. Furthermore, expressing individual clusters of TPR motifs from 
TTC17 might enhance our chances of identifying specific binding partners of TTC17 in the LC-
MS/MS experiments as these individual domains could act like dominant negatives. The same 
approach of only expressing the clusters of TPR motifs from TMTC3 and TTC13 could enhance 
our detection of putative binding partners by LC-MS/MS. 
While the sequential nature of the TPR domains are important, the exact number of TPR 
motifs in a protein can be hard to predict due to discrepancies between available databases and 
algorithms. While UniprotKB predicts that TTC9B has three TPR domains whereas TPRpred, 
another algorithm that predicts TPR domains, predicts that a gap between the first and second 
TPR domains of TTC9B is also a TPR domain (Figure 3.1) (Karpenahalli et al., 2007; UniProt, 
2013). Similarly, TTC17 has two clusters of three TPR domains that likely form two individual 
binding modules while the first orphan TPR motif is most likely not functional, it might not be a 
bona fide TPR motif. Additionally, TTC17 is also a large protein consisting of 1141 amino acids 
and only 238 of these are accounted for in the seven TPR motifs. Thus it is likely that the 
segments of TTC17 that are not TPR motifs would fold into another specific fold. To this end, the 
primary amino acid sequence of TTC17 was analyzed by a variety of algorithms that predicts 
secondary structure and protein domains. However, analysis by UniprotKB, SuperFam and the 
BioSmart 7 algorithms did not detected any other domains in TTC17 (Karpenahalli et al., 2007; 
Letunic et al., 2012; UniProt, 2013). 
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In addition to their TPR domains, TMTC3 and TMTC4 have eight and nine hydrophobic 
domains, respectively, some of which are used as transmembrane domains (Figure 3.1) (Hessa et 
al., 2011). Due to the number of the transmembrane domains and the presence of charged and 
hydrophilic residues in some of these putative transmembrane domains, TMTC3 and/or TMTC4 
could form a pore in the ER membrane. Additionally, proteins with TPR domains are frequently 
found in protein complexes designed for post-translational translocation, such as Tom70 
(mitochodria), Toc64 (chloroplast), PEX5 (peroxisome) and Sec72p (yeast ER) (Feldheim and 
Schekman, 1994; Gatto et al., 2000; Qbadou et al., 2006; Young et al., 2003). In this light, the 
interaction between TMTC4 and p97 is of great interest since p97 is a cytoplasmic AAA ATPase 
associated with pulling misfolded secretory proteins out of the ER membrane and into the 
cytoplasm for ubiquitination and degradation by the 26S proteasome (Smith et al., 2011). If an 
interaction between TMTC4 and p97 can be verified, it could imply that TMTC4 is important to 
form a pore for misfolded proteins in the ER membrane. While a number of proteins have been 
proposed to function as the conduit for misfolded proteins to pass through the ER membrane and 
into the cytoplasm, the matter is still controversial (Carvalho et al., 2010; Lilley and Ploegh, 
2004; Plemper et al., 1997; Ploegh, 2007; Ye et al., 2004). Since posttranslational translocation is 
a complicated processes, nucleation of a multi-protein complex is likely required, thus TMTC4 is 
an ideal candidate to form such a pore with its multiple hydrophobic domains and TPR motifs. 
While this is a highly attractive hypothesis, it is possible that TMTC4 readily misfolds and 
becomes targeted for degradation and subsequent extraction by p97. Nevertheless, we have 
characterized four novel ER adapters, TMTC3, TMTC4, TTC13 and the TTC17, which might aid 
in the compartmentalization of the ER into subdomains. 
Materials and methods 
Reagents and plasmids  
 
74 
 
Dulbecco’s modified Eagle medium (DMEM), fetal calf serum (FCS), penicillin, 
streptomycin, and Zysorbin were purchased from Invitrogen. 1-deoxynojirimycin (DNJ) and 
Easy-Tag [
35
S]-Cys/Met were purchased from Toronto Research Chemicals and PerkinElmer, 
respectively. S-protein agarose beads and S-tag antibody were purchased from EMD Millipore. 
EndoH, PNGase F, AMV first strand synthesis kit, and all cloning reagents were purchased from 
New England Biolabs. FastStart Sybr Green qPCR mix was purchased from Roche, and all 
primers were acquired from IDT DNA. Anti-mouse-HRP IgG, anti-rabbit-HRP IgG, and protein 
A Sepharose CL-4B were purchased from GE Healthcare. Antibodies directed towards the 
following antigens were also purchased as follows: myc (Cell Signaling); calnexin (Enzo Life 
Sciences); calreticulin (Thermo scientific); and GM130 (BD Biosciences). TMTC3, TMTC4, 
TTC9B, TTC13, TTC17, TTC35 and NASP were open reading frames were acquired by 
harvesting total RNA from HEK293T cells followed by reverse transcriptase to form cDNA. The 
cDNA was then PCR amplified and cloned into a pcDNA3.1 A-, a plasmid harboring either a C-
terminal S- or myc- tag, using standard molecular biology techniques. The individual clusters of 
TPR domains of TMTC3, TMTC4, TTC13 and TTC17 were cloned into a pcDNA3.1 A- S-tag 
backbone, which was modified to possess a N terminal BiP signal sequence prior to the multiple 
cloning site and a KDEL sequence after the C-terminal S-tag. All other chemicals were obtained 
from Sigma-Aldrich.  
Tissue culture 
Human embryonic kidney (HEK) 293T or Cos7 cells were grown in DMEM 
supplemented with 10% fetal calf serum, 100 U/ml penicillin, and 100 mg/ml streptomycin, and 
incubated at 37 
0
C in 5% CO2. Cells were transfected with polyethylenimine (PEI) and the 
appropriate plasmids for 16 hr. 
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Confocal microscopy 
Cos7 cells were transfected with TMTC3, TMTC4, TTC9B TTC13, TTC17, TTC35 and 
NASP harboring a C-terminal S-tag as indicated. Cells were fixed in 4% paraformaldehyde in 
PBS for 10 min followed by permeabilization for 10 min in methanol at -20 
O
C. Slides were re-
hydrated in immunostaining buffer (20 mM HEPES [pH 7.5], 150 mM NaCl, 2 mM MgCl2, 1 
mM EGTA, and 2% bovine serum albumin) and stained with ERp57, GM130 or S-tag antisera in 
immunostaining buffer. Slides were rinsed and mounted onto cover slips with VectaShield 
(Vector Laboratories), which contained DAPI for staining of the nucleus. Images were obtained 
with a Flouview 1000 MPE, IX81 motorized inverted research microscope (Olympus Inc.) 
equipped with a Hamamatsu C8484-05G camera. All images were acquired with a Plan Apo N 
60x 1.42NA lens and processed by using the FV10-ASW and the Adobe Photoshop software.  
qRT-PCR 
HEK293T cells were treated with 5 mM dithiothreitol, 0.5 µM thapsigargin, 5 µg/ml 
tunicamycin or starved for Cys and Met for 8 hs prior to RNA isolation with RNeasy Mini Kit 
(Qiagen). One µg of purified RNA was reverse transcribed into cDNA using the AMV Reverse 
Transcriptase kit (New England Biolabs). Quantitative real time polymerase chain reactions 
(qRT-PCR) were performed in 20 µL reactions using FastStart universal SYBR Green master 
(Rox) kit (Roche Diagnostics Corp.) on a Mx3000P real-time PCR machine (Agilent 
Technologies Inc) according to manufacturer’s instructions. Changes in mRNA levels were 
calculated using the change in cycle threshold value method with β-actin as the reference gene 
(Pfaffl, 2001). Statistical analysis of the data was calculated using GraphPad Prism 4.0 (GraphPad 
Software). The following primers were used: Beta actin (5’ GCACTCTTCCAGCCTTCC 3’, 5’ 
TGTCCACGTCACACTTCATG 3’), BiP (5’ GCTGTTTCTATTGGCCTTTCTC 3’, 5’ 
TGTCTCTTTCACCAGCATCG 3’), XBP1 (5’ GCCCTGGTTGCTGAAGAG 3’, 5’ 
GTCAATACCGCCAGAATCC 3’), TMTC3 (5’ TTTTCCTAAGCCATCCCCTG 3’, 5’ 
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CAAAACCACAAAAGAGGCTG 3’), TMTC4 (5’ CCCTCATTAAGTCCATCAGCG 3’, 5’ 
ATAACGAGAAATCCCAGGCC 3’),TTC9B (5’ CTGAAGATGAATCGTTGCAG 3’, 5’ 
GGGAAGTTACATGGTGAGGTG 3’), TTC13 (5’ CCTGATGCAATATGAAACACCTG 3’, 5’ 
TCAACCGTGTCTTCCCATTC 3’), TTC17 (5’ CCAAGCAAACCTAGAGATCAC 3’, 5’ 
GTACTCACGATGGCAGTCAG 3’), TTC35 (5’ TGGCAGTCACAGAGTCAAG 3’, 5’ 
CGAATGGCAATCTTACGCTTTC 3’), NASP (5’ CTGGAGTTGGCAAGAATGG 3’, 5’ 
TCTCAACTCTTCCCTTGCTTC 3’). 
Glycosylation assay 
HEK293T cells were transfected as indicated for 16 hr followed by radiolabeling of 
proteins with [
35
S]-Cys/Met was performed for 1 hr. Cells were lysed in MNT buffer (0.5% 
Triton X-100, 20 mM MES, 100 mM NaCl, 20 mM Tris-HCl [pH 7.5]). All steps were conducted 
at 4 
0
C. The post-nuclear supernatant (PNS) was isolated by centrifugation followed by pre-
clearing with Zysorbin for 1 hr. Cleared supernatant was incubated with S-protein agarose beads 
overnight and subsequently washed twice with MNT buffer. After the final MNT wash, 
glycosylation assays were performed by adding appropriate buffers and either no treatment, Endo 
H or PNGase F enzymes according to the manufacturer’s protocol. Finally, reducing sample 
buffer was added to all samples, and they were analyzed by SDS-PAGE. 
 
Alkaline extraction 
HEK293T cells were transfected as indicated for 16 hr followed by radiolabelling for 1 hr 
with [
35
S]-Cys/Met. Cells were fractionated in an isotonic buffer and an untreated sample was 
retained (Whole cell lysate, WCL). Cell lysate is centrifuged at low speed to pellet nuclei (N). 
The remaining post nuclear supernatant (PNS) is ultracentrifuged to separate cytosol (C) from the 
total membrane fraction (TM). Alkaline extraction was performed on part of the TM fraction by 
incubation with Na2CO3 pH 11.5 for 30 min at 4 
O
C. Finally, an ultracentrifugation step was 
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employed to separate luminal proteins in the supernatant (S) from integral membrane proteins in 
the pellet (P). The pH was corrected in the alkaline extraction tube to ~ pH 7 by addition of HCl. 
MNT was added in excess to all samples and affinity purification (AP) or immunoprecipitation 
(IP) was performed as indicated. 
Trypsin protection assay 
HEK293T cells were transfected as indicated for 16 hr followed by radiolabeling with 
[
35
S]-Cys/Met. ER microsomes were purified by ultracentrifugation and resuspended in 
homogenization buffer. Aliquots of the ER microsomes were treated with Triton X-100 and 
Trypsin for 10 min at 27 ˚C as indicated. Trypsin was inhibited with soybean trypsin inhibitor 
followed by an AP with S-protein agarose beads as described above and analysis on a SDS-
PAGE. 
Shotgun LC-MS/MS and silver stain 
HEK293T cells were transfected as indicated by isotonic fractionation and 
ultracentrifugation to purify microsomes. These microsomes were then resuspended in a MS (50 
mM Hepes pH 7.4, 300 mM NaCl, 25 mM EDTA) buffer supplemented with either 1% Triton X-
100 or 1% CHAPS detergent followed by AP with S-protein agarose beads. APs were washed 
twice in MS buffer and twice in 50 mM ammonium carbonate before addition of reducing sample 
buffer. A portion of the sample was loaded onto a SDS-PAGE and subject to silver staining to 
verify enrichment of putative binding partners. Once appropriate enrichment had been observed, a 
portion of the AP was loaded onto a SDS-PAGE gel, and the dye front was allowed to migrate ~ 
1 cm into the resolving gel. The sample containing area of the gel was excised and prepared for 
in-gel trypsin digestion. Tryptic peptides generated by trypsinization were loaded on a LC-
MS/MS instrument followed by protein identification. Proteins were scored based on the number 
of unique peptides that were identified from the corresponding protein. 
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Immunoblotting and affinity purification  
HEK293T cells were transfected with TMTC3-S-tag or TMTC4-S-tag, and 16 hr post 
transfection cells were harvested. Total membranes were purified as described previously 
followed by either resuspension in gel loading buffer or affinity purification with S-protein 
agarose beads. Immunoblots were performed with antisera against indicated proteins. 
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Name Mock TMTC3 TMTC4
Fatty acid synthase 2 28 34
DNA-dependent protein kinase catalytic subunit 5 21 31
BiP 0 3 26
HSPA8 0 2 26
P97 0 1 21
Calnexin 0 0 20
Heat shock protein HSP 90-beta 1 6 19
Heat shock 70 kDa protein 1A/1B 2 3 18
Leucine-rich PPR motif-containing protein, mitochondrial 1 6 16
Tubulin beta chain 3 7 16
Transcription intermediary factor 1-beta 2 6 14
Tubulin alpha-1B chain 5 5 14
Beta-actin-like protein 2 9 9 13
Clathrin heavy chain 1 6 9 13
Pyruvate kinase isozymes M1/M2 1 3 11
Importin 0 2 11
Coatomer subunit alpha 0 2 10
Heterogeneous nuclear ribonucleoprotein U 4 7 10
Probable ATP-dependent RNA helicase DDX5 0 2 10
Ubiquitin-60S ribosomal protein L40 1 4 10
CAD protein 0 3 9
Poly [ADP-ribose] polymerase 1 3 7 9
Heterogeneous nuclear ribonucleoprotein K 0 3 8
SERCA2 0 0 8
# of unique peptides
 
 
Table 3.1 Putative binding partners of TMTC3 and TMTC4. 
 
Putative binding partners of TMTC1 and TMTC2 as determined by LC-MS/MS. Proteins are 
ranked by number of unique peptides identified that originates from the corresponding proteins 
compared to mock transfected cells.  
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Figure 3.1 Putative ER adapter proteins.  
 
Our screen for novel secretory adapter proteins identified nine proteins. The number and position 
of tetratricopeptide repeat (TPR) (red rectangles), hydrophobic domains (green squares), N-linked 
glycans (black tree-like structures), proline rich domains (blue squares) and histone binding 
domains (brown rectangles) are color-coded. 
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Figure 3.1 TMTC3, TMTC4, TTC13 and TTC17 co-localize with an ER marker 
 
Cellular localization of TMTC3, TMTC4, TTC9B, TTC13, TTC17 TTC35 and NASP was 
investigated by confocal microscopy. Cos7 cells were transfected as indicated with TMTC3, 
TMTC4, TTC9B, TTC13, TTC17 TTC35 and NASP harboring a C-terminal S-tag. Fixed cells 
were stained with S-tag, ERp57 (ER) or GM130 (Golgi) antisera. Nuclei were visualized by 
DAPI staining (blue). Scale bars represent 10 µm.   
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Figure 3.3 TMTC4, TTC9B, TTC13 and TTC17 are upregulated by oxidative stress. 
 
HEK293T cells were treated with regular growth media or media containing 5 mM DTT, 1 μM 
thapsigargin, 5 μg/mL tunicamycin or lacking Cys and Met (-Cys/Met) for 8 hr prior to RNA 
purification. RNA was reverse transcribed to cDNA followed by qRT-PCR with appropriate 
primers, and changes in gene expression were calculated using beta actin as a reference. 
Statistical significance between treatment groups was determined using one-way ANOVA 
followed by Tukey multiple comparison tests. *, ** and *** indicates a P-value of less than 0.05, 
0.01 and 0.001, respectively. Error bars represent standard deviation from at least three 
independent experiments. 
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Figure 3.4. TMTC3 and TMTC4 are ER membrane proteins whereas TTC13 and TTC17 are 
soluble. 
 
(A) HEK293T cells were transfected with S-tagged TMTC3, TMTC4, TTC9B, TTC13, TTC17, 
TTC35, or NASP as indicated and radiolabeled for 1 hr with [
35
S]-Cys/Met. Cells and media were 
collected. TMTC3, TMTC4, TTC9B, TTC13, TTC17, TTC35, or NASP collected from the media 
and lysed cells were affinity purified using S-protein agarose. Samples were then subjected to a 
glycosylation assay with either Endo H (lanes 2, 5, 8 and 11) or PNGase F (lanes 3, 6, 9 and 12) 
digestion as indicated. Reducing sample buffer was added, and the samples were analyzed by 
7.5% SDS-PAGE. (B) HEK293T cells expressing S-tagged TMTC3, TMTC4, TTC9B, TTC13, 
TTC17, TTC35, or NASP were radiolabeled for 1 hr followed by homogenization, fractionation 
and alkaline extraction. The fractions collected were whole cell lysate (WCL), nucleus (N), 
cytosol (C), total membrane (TM), as well as supernatant (S) and pellet (P) fractions upon 
alkaline extraction of the TM. Samples were resolved by reducing 7.5% SDS-PAGE.  
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Figure 3.5. The TPR domains of TMTC3, TMTC4, TTC13 and TTC17 are facing the ER lumen. 
 
TMTC3-S-tag, TMTC4-S-tag, TTC13-S-tag or TTC17-S-tag was expressed in HEK293T cells. 
After radiolabeling for 1 hr, cells were homogenized, and microsomes were purified by 
ultracentrifugation then resuspended in homogenization buffer. Aliquots of the ER microsomes 
were incubated for 10 min at 27 ˚C without (lanes 1, 5 and 9) or with 0.1% Triton X-100 and 10 
µg trypsin (lanes 4, 8 and 12) as indicated. TMTC3, TMTC4, TTC13, and TTC17 were affinity 
purified with S-protein agarose beads. Samples were resolved on a reducing 9% SDS-PAGE.  
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Figure 3.6. TMTC4 interacts with the lectin chaperone calnexin. 
 
(A) HEK293T cells were transfected as indicated and homogenized prior to purification of 
microsomes by ultracentrifugation. TMTC3 or TMTC4 was isolated with its associated factors 
from microsomes in MS buffer using S-protein agarose affinity precipitation. A portion of the 
samples was loaded onto a SDS-PAGE and silver stained to verify enrichment of putative binding 
partners. A separate portion of the affinity-purified sample was run on a short SDS-PAGE before 
excision of the sample and in gel trypsin digestion. Tryptic peptides were injected into a LC-
MS/MS instrument followed by peptide identification. (B) HEK293T cells expressing TMTC3 or 
TMTC4 were harvested in homogenization buffer. A portion of the cell homogenate was 
subjected to ultracentrifugation and resuspended in reducing sample buffer. This was considered 
the total membrane fraction. An excess of MNT was added to an equal amount of cell 
homogenate and subjected to S-protein agarose affinity precipitation. Proteins were detected by 
immunoblotting with appropriate antisera directed against the S-tag epitope, calnexin (CNX), BiP 
and calreticulin (CRT). 
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CHAPTER IV 
 
CONCLUSIONS AND FUTURE DIRECTIONS 
The endoplasmic reticulum (ER) consists of a continuous network of ER sheets and 
tubules that extend throughout the mammalian cell. Although continuous, a compartmentalization 
of the ER into sub-domains has been observed (Lynes and Simmen, 2011). It has been proposed 
that these ER sub-domains are maintained by adapter proteins that nucleate protein complexes. 
Tetratricopeptide repeats (TPR) are common adapter motifs, which are capable of nucleating 
multi-protein complexes (D'Andrea and Regan, 2003). To this end we conducted an in silico 
search for TPR containing proteins that are targeted to the secretory pathway. This search and 
subsequent experiments lead to the identification of TMTC1, TMTC2, TMTC3, TMTC4, TTC13 
and TTC17 as novel ER TPR containing proteins (Figure 1.6).  
TMTC1 and TMTC2 are novel regulators of calcium homeostasis 
TMTC1 and TMTC2 were found to reside in protein complexes of 500-600 kDa in size 
by the sucrose sedimentation assay (Figure 2.5D). While the exact nature of the TMTC1 and 
TMTC2 complexes are not known, both the sucrose gradient and the co-affinity purification (AP) 
imply that SERCA2B is part of the TMTC1 and TMTC2 complexes and that calnexin is part of 
the TMTC2 complex. (Figure 2.5B and D). Additionally, some TPR proteins have been proposed 
to use regions of their TPR domains, which are not used for ligand binding, for dimerization 
(Jinek et al., 2004; Wu and Sha, 2006). Thus, it is possible that the complexes observed contain 
homoligomers of TMTC1 and TMTC2. 
A short-coming of the current study is that we do not have an antibody against TMTC1 
and TMTC2, which allows us to study the endogenous proteins.  To circumvent this problem we 
could use the TALON system to create a cell line that stably expresses S-tagged TMTC1 and 
TMTC2 under their endogenous promoters (Gaj et al., 2013). First, this approach is more likely to 
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preserve the appropriate stoichiometry of the TMTC1 and TMTC2 complexes. Secondly, it would 
allow us to verify the interactions between TMTC1 and TMTC2 with SERCA2B, and TMTC2 
with calnexin without relying on overexpression. Thirdly, it would allow us to investigate if 
TMTC1 or TMTC2 are targeted to an ER sub-domain, since the delicate organization of the ER 
might be distorted by over expressing TMTC1 and TMTC2. Since calnexin has been proposed to 
modulate SERCA2B activity at the mitochondria associated membranes (MAM) (Lynes et al., 
2013) and TMTC2 interacts with calnexin whereas TMTC1 does not, an interesting hypothesis is 
that TMTC2 resides in the MAMs whereas TMTC1 could be interacting with the SERCA2B in 
areas beyond these contact points. Taken together, a clearer view of the functions of TMTC1 and 
TMTC2 would be available with either antibodies against the endogenous protein or with stable 
cell lines expressing tagged versions of TMTC1 or TMTC2. 
 While the TPR domains of TMTC1 and TMTC2 were important for binding SERCA2B 
(Figure 2.6), it is still unclear if this is the only intended ligand for the TPR motifs of TMTC1 and 
TMTC2. It is likely that some interactions were missed by our mass spectrometry analysis since 
the AP was performed in 1% Triton X-100. To circumvent this problem, the mass spec analysis 
could be repeated in a gentler detergent or with a cross linker. Alternatively, we could express the 
TMTC1
TPR
 and TMTC2
TPR
 constructs and perform a mass spectrometry analysis with these 
constructs to identify binding partners specifically of the TPR domains. 
Live cell calcium measurements illustrated that cells transfected with either TMTC1
GFP
 or 
TMTC2
GFP
 released less calcium upon simulated release of intracellular calcium. Additionally, 
knock down of TMTC1 and TMTC2 caused an increased amount of calcium release upon 
stimulation. While the Fura2-AM experiments implicate TMTC1 and TMTC2 in calcium 
homeostasis, a clear understanding of the exact molecular events underlying this observation is 
missing (Figure 4.1). We favor the hypothesis that TMTC1 and TMTC2 affect calcium 
homeostasis by modulating SERCA2B, since both TMTC1 and TMTC2 readily interact with the 
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calcium pump (Figure 2.5B). However, it is important to note that Fura2-AM monitors changes in 
global cytoplasmic calcium. Since multiple calcium pumps and channels exist in a eukaryotic 
cell, it is possible that altering the levels of TMTC1 and TMTC2 also affect, directly or indirectly, 
calcium pumps or channels in the ER, Golgi, mitochondria or plasma membrane (Brini and 
Carafoli, 2009; Clapham, 2007). Transfecting cells with TMTC1
GFP
 or TMTC2
GFP
 and pre-
treating them with the SERCA2B inhibitor thapsigargin prior to the Fura2-AM based calcium 
measurements can address whether TMTC1 and TMTC2 act on other calcium pumps and 
channels. If SERCA2B is the only calcium pump affected, then no difference should be observed 
in the clearance of cytoplasmic calcium. Additionally, changes in ER calcium levels can be 
measured by using the chimeric cameleon protein, which consists of a cyan fluorescent protein 
(CFP), a calmodulin domain and yellow fluorescent protein (YFP) expressed as a single protein 
(Demaurex, 2005; Miyawaki et al., 1997). When calcium binds to the calmodulin domain, a 
structural re-arrangement allows for Förster resonance energy transfer (FRET) between the CFP 
and the YFP, thus the amount of FRET observed can serve as indicator of calcium levels. To test 
if ER calcium levels are modified by TMTC1 or TMTC2, we could express an ER targeted 
cameleon with either knockdown or over expression of TMTC1 and TMTC2 and assay for 
changes in ER calcium levels, before and after stimulation.  
The HEK293T cell line does not utilize calcium signaling for cellular maturation 
processes, nor do the cells reflect changes in calcium stimulation by oscillating internal calcium 
levels, which presents pitfalls in our current study. Thus, it would be more desirable to 
knockdown TMTC1 and TMTC2 and monitor defects in T-cell activation, as this processes is 
dependent on calcium signaling (Feske, 2007). Furthermore, the effect of TMTC1 and TMTC2 on 
oscillation of cytoplasmic calcium could be studied in the rat pancreatic AR42J cell line (Zhao et 
al., 1990). Recent work in AR42J cells implies that a depletion of calcium renders the ER 
environment more reducing, and this effect can be exploited to determine whether altering the 
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levels of TMTC1 or TMTC2 affect disulfide bond formation (Avezov et al., 2013). The interplay 
between calcium homeostasis and the oxidizing environment of the ER highlights that 
perturbations of TMTC1 or TMTC2 can have far reaching consequences for a cell. 
Since elevated ER calcium levels may aid protein folding in the ER (Ong et al., 2010), 
knockdown of TMTC1 and TMTC2 could make the folding process more efficient. Moreover, it 
has been suggested that when misfolded proteins accumulate in the ER, calnexin dissociates from 
SERCA2B at the MAM in order to support protein folding rather than calcium homeostasis 
(Lynes et al., 2013). Therefore, TMTC2 knockdown could further enhance protein folding by 
liberating calnexin from SERCA2B. Taken together, TMTC1 and TMTC2 are novel regulators of 
calcium homeostasis, although the exact molecular mechanisms involved are unclear. 
TMTC3 and TMTC4 are two novel ER membrane TPR containing proteins 
TMTC3 and TMTC4 were identified as two novel ER adapter proteins with their TPR 
domains facing the ER lumen (Figure 4.2). While no clear binding partner has been verified for 
TMTC3, an interaction between TMTC4 and calnexin was observed (Figure 3.6). Furthermore, 
an interaction between TMTC4 and fatty acid synthase and p97, a cytoplasmic ATPase associated 
with diverse cellular activities, was suggested through mass spectrometry. The interaction with 
TMTC4 and fatty acid synthase or p97 would imply a role for TMTC4 in lipid synthesis or 
degradation of misfolded proteins, respectively (Jensen-Urstad and Semenkovich, 2012; Wolf and 
Stolz, 2012). Alternatively, TMTC4 could regulate the controlled degradation of an enzyme(s) 
important for certain lipids. This would be similar to the cholesterol regulation in the ER, wherein 
the rate limiting enzyme is degraded when cholesterol is abundant (Goldstein and Brown, 1990). 
To address if TMTC4 is indeed important for degradation of misfolded proteins, we will 
knockdown or overexpress TMTC4 and monitor the disposal of misfolded secretory proteins. 
Alternatively, TMTC4 could be important for the proper maturation of secretory proteins, by 
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virtue of the interaction with calnexin. To this end, secretion efficiency of a variety of secretory 
proteins will be addressed with either over expression of knockdown of TMTC4.  
The mass spectrometry data did not show an interaction between TMTC4 and any known 
ER ligase. This could be attributed to using inadequate buffering conditions, since interactions 
between ER luminal factors and ER membrane E3 ligases are abolished in 1% Triton X-100 
buffer (Christianson et al., 2012). Thus, the mass spectrometry approach could be retried by using 
gentler detergents or cross linkers, and verification of these interactions will then be tested in a 
gentler detergent buffer. Furthermore, our current list of putative TMTC4 binding partners (Table 
3.1), likely contains other bona fide binding partners of TMTC4. To this end we intend to acquire 
the appropriate antisera against putative binding partners and address binding by co-AP and 
western blots. 
To address if the TPR motifs of TMTC4 is important for recognizing calnexin, we could 
express a truncated form of the TMTC4 that contains a N-terminal signal sequence, the TPR 
motifs and a C-terminal tag and assess binding by AP and western blots. If an interaction is 
observed, the experiment will be performed in conditions that abolish the binding between 
calnexin and N-linked glycans (Hebert et al., 1995). Once additional binding partners have been 
verified from the mass spectrometry, binding to the TPR motifs of TMTC4 will be addressed as 
well. In conclusion, we have identified TMTC3 and TMTC4 as ER membrane proteins with 
luminally oriented TPR domains, and yet unknown functions. 
TTC13 and TTC17 are two novel ER luminal TPR containing proteins 
TTC13 and TTC17 where the only two luminal TPR containing ER proteins identified in 
our screen (Figure 4.2), which puts certain limitations on the function of these adapters. Since 
TTC13 and TTC17 are luminal, they are not expected to interact with any cytoplasmic 
components, unless part of a ternary complex. Additionally, most ER sub-domains tend to be 
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anchored in the ER membrane (Lynes and Simmen, 2011). This could mean that TTC13 and 
TTC17 could serve a more general ER function encountered throughout the domains, rather than 
a function in a specialized ER sub-domain. Anchoring a protein complex in a membrane can 
enhance complex formation by limiting diffusion to two dimensions (Good et al., 2011). It is also 
possible that the interactions between TTC13 and TTC17 and their respective ligands are less 
stable then what was observed for TMTC1, TMTC2 and TMTC4, which would hamper the 
detection of binding partners. This notion is supported by the fact that no enrichment of putative 
binding partners was observed on a silver stained SDS-PAGE.  
Attempts to identify binding partners of TTC13 and TTC17 by AP followed by silver 
staining of a SDS-PAGE have failed to yield a significant enrichment of putative binding 
partners, thus the experimental conditions must be re-optimized. Specifically, we will perform the 
AP in more gentle detergents and we could employ cross linkers to covalently trap interactions in 
the ER. Although cross linking may increase the number of false positives, it could help us 
identify genuine interactions. Additionally, the TTC13 and TTC17 TPR domains could act as 
dominant negatives for their respective binding partners; which, if true, can be exploited to 
potentially trap the binding partners on the respective individual TPR domains. Finally, an amber 
suppressor codon could be utilized to label TTC13 and TTC17 on specific sites with a 
photoactivatable cross linker and identify binding partners via LC-MS/MS (Hino et al., 2005). 
Taken together, a number of experimental methods such as cross linkers and different detergents 
can be employed to identify the unknown binding partners for TTC13 and TTC17. These future 
experiments will be followed by experiments to determine the purpose of these interactions. 
TTC9B could be important for ER stress signaling 
Since TTC9B appears to be a cytoplasmic protein, it was unexpected that TTC9B was 
transcriptionally up-regulated by oxidative stress (Figure 3.3). This could imply that TTC9B is 
involved in ER stress signaling from a cytoplasmic aspect, and may be critical for maintaining 
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and restoring ER homeostasis upon insult. To investigate the contribution of TTC9B in ER stress 
signaling, we could knockdown TTC9B with or without various stress inducing agents and assess 
whether there is a change in activation of either of the three branches of the unfolded protein 
response (Hetz, 2012). This data highlights the importance of the crosstalk between the ER and 
other organelles and the role of cytoplasmic factors in shaping and relaying messages across the 
ER membrane.  
Summary 
In this thesis we have identified six novel ER proteins with multiple TPR motifs, which 
could aid in the compartmentalization of the ER. Subsequent experiments implied that TMTC1 
and TMTC2 are novel regulators of calcium homeostasis, which opens up new avenues of 
studying calcium signaling and homeostasis. Conversely, no clear function can yet be assigned to 
TMTC3, TMTC4, TTC13 or TTC17, although preliminary studies are underway in our 
laboratory. Overall, this strategy was successful in identifying novel ER proteins with TPR 
motifs. The method can be applied to detect other common adapter motifs such as PDZ or 
ankyrin repeats in the ER or other organelles that have recognizable targeting sequences such as 
the mitochondria or chloroplast (Bhattacharyya et al., 2006; Good et al., 2011) 
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Figure 4.1 TMTC1 and TMTC2 are important for ER calcium homeostasis. 
 
(A) Both TMTC1 and TMTC2 were found to interact with SERCA2B, and TMTC2 was also 
found to interact with calnexin. Overexpression of TMTC1 or TMTC2 caused a reduction in 
stimulated calcium release, implying a defect in the ability of SERCA2B to sequester calcium. 
Hydrophobic domains are denoted by green rectangles and TPR motifs are denoted by red 
hexagons. (B) Knockdown of either TMTC1 or TMTC2 caused an increase in stimulated calcium 
release, which is indicative of enhanced sequestering by SERCA2B resulting in elevated ER 
calcium levels. Simultaneous overexpression or knockdown of TMTC1 and TMTC2 did not 
provide any additive effect, implying that they serve redundant functions.  
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Figure 4.2 TMTC3, TMTC4, TTC13 and TTC17 are novel ER TPR proteins. 
 
TMTC3 and TMTC4 are ER membrane proteins whereas TTC13 and TTC17 are ER luminal 
proteins. An interaction between TMTC4 and calnexin was verified by co-AP. Hydrophobic 
domains are denoted by green rectangles, TPR motifs are denoted by red hexagons and the 
asparagine (N)-linked glycan is denoted by the black branched structure on TMTC4. 
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APPENDIX A 
EDEM1 RECOGNITION AND DELIVERY OF MISFOLDED PROTEINS TO THE 
SEL1L-CONTAINING ERAD COMPLEX. 
 
(Cormier et al, 2009) 
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APPENDIX B 
THE ROLE OF UDP-GLC:GLYCOPROTEIN GLUCOSYLTRANSFERASE 1 IN THE 
MATURATION OF AN OBLIGATE SUBSTRATE PROSAPOSIN 
(Pearse et al, 2010) 
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APPENDIX C 
SORTING THINGS OUT THROUGH ENDOPLASMIC RETICULUM QUALITY 
CONTROL. 
 
(Tamura et al, 2010) 
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